Insights into the structure and function of the aggregate-reactivating molecular chaperone CLPB by Nagy, Maria
  
INSIGHTS INTO THE STRUCTURE AND FUNCTION OF THE AGGREGATE-
REACTIVATING MOLECULAR CHAPERONE CLPB 
 
 
by 
 
 
MARIA NAGY 
 
 
B.S., Babes-Bolyai University, Cluj-Napoca, Romania, 1997 
M.S., Babes-Bolyai University, Cluj-Napoca, Romania, 1998 
 
 
 
 
AN ABSTRACT OF A DISSERTATION 
 
 
submitted in partial fulfillment of the requirements for the degree 
 
 
DOCTOR OF PHILOSOPHY 
 
 
Graduate Biochemistry Group  
College of Arts and Sciences 
 
 
 
 
 
 
 
KANSAS STATE UNIVERSITY 
Manhattan, Kansas 
 
 
2008 
 
  
Abstract 
 ClpB is a bacterial heat-shock protein that disaggregates and reactivates 
strongly aggregated proteins in cooperation with the DnaK chaperone system.  ClpB 
contains two ATP-binding AAA+ modules, a linker coiled-coil domain, and a highly 
mobile N-terminal domain. It forms ring-shaped hexamers in a nucleotide-dependent 
manner. The unique aggregation reversing chaperone activity of ClpB involves ATP-
dependent translocation of substrates through the central channel in the ClpB ring. The 
initial events of aggregate recognition and the events preceding the translocation step 
are poorly understood. In addition to the full-length ClpB95, a truncated isoform ClpB80, 
that is missing the whole N-terminal domain, is also produced in vivo.  
Various aspects of the structure and function of ClpB were addressed in this 
work. The thermodynamic stability of ClpB in its monomeric and oligomeric forms, as 
well as the nucleotide-induced conformational changes in ClpB were investigated by 
fluorescence spectroscopy. Equilibrium urea-induced unfolding showed that two 
structural domains-the small domain of the C-terminal AAA+ module and the coiled-coil 
domain-were destabilized in the oligomeric form of ClpB, which indicates that only those 
domains change their conformation or interactions during formation of the ClpB rings. 
Several locations of Trp-fluorescence probes were also found to respond to nucleotide 
binding. 
The biological role of the two naturally-occurring ClpB isoforms was also 
investigated. We discovered that ClpB achieves optimum chaperone activity by 
 synergistic cooperation of the two isoforms that form hetero-oligomers. We found that 
ClpB95/ClpB80 hetero-oligomers form preferentially at low protein concentration with 
higher affinity than homo-oligomers of ClpB95. Moreover, hetero-oligomers bind to 
aggregated substrates with a similar efficiency as homo-oligomers of ClpB95, do not 
show enhanced ATPase activity over that of the homo-oligomers, but display a strongly 
stimulated chaperone activity during the reactivation of aggregated proteins. We 
propose that extraction of single polypeptides from aggregates and their delivery to the 
ClpB channel for translocation is the rate-limiting step in aggregate reactivation and that 
step is supported by the mobility of the N-terminal domain of ClpB. We conclude that 
the enhancement of the chaperone activity of the hetero-oligomers is linked to an 
enhancement of mobility of the N-terminal domains. 
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Abstract 
ClpB is a bacterial heat-shock protein that disaggregates and reactivates strongly 
aggregated proteins in cooperation with the DnaK chaperone system.  ClpB contains 
two ATP-binding AAA+ modules, a linker coiled-coil domain, and a highly mobile N-
terminal domain. It forms ring-shaped hexamers in a nucleotide-dependent manner. The 
unique aggregation reversing chaperone activity of ClpB involves ATP-dependent 
translocation of substrates through the central channel in the ClpB ring. The initial 
events of aggregate recognition and the events preceding the translocation step are 
poorly understood. In addition to the full-length ClpB95, a truncated isoform ClpB80, 
that is missing the whole N-terminal domain, is also produced in vivo.  
Various aspects of the structure and function of ClpB were addressed in this 
work. The thermodynamic stability of ClpB in its monomeric and oligomeric forms, as 
well as the nucleotide-induced conformational changes in ClpB were investigated by 
fluorescence spectroscopy. Equilibrium urea-induced unfolding showed that two 
structural domains-the small domain of the C-terminal AAA+ module and the coiled-coil 
domain-were destabilized in the oligomeric form of ClpB, which indicates that only those 
domains change their conformation or interactions during formation of the ClpB rings. 
Several locations of Trp-fluorescence probes were also found to respond to nucleotide 
binding. 
The biological role of the two naturally-occurring ClpB isoforms was also 
investigated. We discovered that ClpB achieves optimum chaperone activity by 
 synergistic cooperation of the two isoforms that form hetero-oligomers. We found that 
ClpB95/ClpB80 hetero-oligomers form preferentially at low protein concentration with 
higher affinity than homo-oligomers of ClpB95. Moreover, hetero-oligomers bind to 
aggregated substrates with a similar efficiency as homo-oligomers of ClpB95, do not 
show enhanced ATPase activity over that of the homo-oligomers, but display a strongly 
stimulated chaperone activity during the reactivation of aggregated proteins. We 
propose that extraction of single polypeptides from aggregates and their delivery to the 
ClpB channel for translocation is the rate-limiting step in aggregate reactivation and that 
step is supported by the mobility of the N-terminal domain of ClpB. We conclude that 
the enhancement of the chaperone activity of the hetero-oligomers is linked to an 
enhancement of mobility of the N-terminal domains. 
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CHAPTER 1 - Introduction 
 
Protein misfolding and aggregation 
Proper cell function and viability depends not only on the presence of correctly 
folded, functional proteins, but also on the efficiency of the protein folding process and 
the ability of the already folded proteins to remain in a functional state. Cells have 
evolved elaborate strategies to control the protein folding process and to ensure that the 
correctly folded proteins remain in a functional state throughout the lifespan of the 
organism. 
Protein folding has been long considered one of the most exciting and challenging 
processes of modern biology. Major advances in the understanding of the mechanism 
of the folding process have been made since the famous experiment of Anfinsen on the 
in vitro folding of ribonuclease A (Anfinsen, 1973). The original observation - that the 
information required for correct folding is encoded in the primary amino acid sequence 
of the protein - still remains one of the fundamental principles that govern protein 
folding.  However, protein folding is a complex process whether it happens in the natural 
setting of the living cells or under laboratory conditions. In vitro refolding experiments 
revealed that some smaller proteins (with less than 100 residues) fold, and thus find 
their lowest-energy/most stable structure, by following simple two-state kinetics. In 
contrast, folding of larger proteins, especially the ones composed of multiple domains, 
frequently involves partly folded intermediate states on the way to the native 
conformation. These partly folded intermediates expose regions of the polypeptide 
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(mostly hydrophobic) that would normally become buried in the native conformation. As 
a result, these non-native intermediate states populated during the folding or unfolding 
process  are prone to misfolding and have a high tendency to associate with each other 
and form aggregates with low solubility (Fig. 1.1) (Horwich, 2002). This non-native self-
association process is even more complex, but at the same time more relevant, in the 
crowded environment of living cells. It is important to mention that the misfolding 
aggregates described above are different from protein precipitates that retain the native 
folded conformation like the ones formed by salting out or isoelectric precipitation (Fink, 
1998).  
Protein aggregation can also become a major hassle in biotechnology and in 
research laboratories. Inclusion body formation during protein overexpression in 
bacteria, aggregation during protein purification or during protein refolding from 
denaturant as well as during the protein lyophilization process, are probably the most 
familiar examples. But most importantly, protein misfolding and aggregation represents 
a major threat for living organisms, as exemplified by the large number of pathological 
conditions associated with severe human diseases.  
Protein misfolding diseases 
Some protein misfolding diseases arise as a result of defective folding leading to a 
decrease in the functional protein (e.g. cystic fibrosis (Thomas et al., 1995), and some 
types of cancer (Bullock and Fersht, 2001)) or improper trafficking (e.g. α1-antitrypsin 
deficiency (Thomas et al., 1995)). However, the majority of the protein misfolding-
related human diseases-commonly referred to as protein deposition diseases-are 
associated with the abnormal deposition of proteins or protein fragments within cells or 
 3
in the extracellular space. In general, when the aggregates are formed extracellularly, 
as it happens with the majority of the cases, they are referred to as amyloid deposits or 
plaques and the corresponding diseases are known as amyloidoses. When the amyloid-
like aggregates are localized inside of the cell, they are often called intracellular 
inclusions. Aggresomes and Lewy or Russell bodies are well known examples of 
intracellular inclusion bodies. Disease-associated aggregates can accumulate in the 
brain of affected individuals as in the case of the neurodegenerative disorders: 
Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic 
lateral sclerosis (ALS). Amyloid-like aggregate accumulation can also occur in a tissue 
other than the brain; in certain diseases it can occur in a single type of tissue as in the 
case of non-neuropathic localized diseases, or aggregation can be detected even in 
multiple tissues as in non-neuropathic systemic disorders. Cataract, type II diabetes, 
and inclusion-body myositis are examples of localized diseases, while senile systemic 
amyloidosis, lysozyme amyloidosis, and fibrinogen amyloidosis are examples of 
systemic non-neuropathic diseases (Chiti and Dobson, 2006).  
The amyloid deposits associated with the overwhelming majority of the protein 
deposition diseases are characterized by highly stable and organized thread-like 
filamentous structures named amyloid fibrils (or fibers) made up of several laterally 
associated protofilaments. The amyloids associated with the various diseases are all 
enriched in β-sheets, and stabilized by intermolecular hydrogen bonds between them. 
Also, it is widely accepted that they all share a core “cross-β” architecture, where the β-
strands are oriented perpendicular to the main axis of the fiber, while the resulting β-
sheets run parallel to it (Sunde and Blake, 1997; Serpell, 2000). This core structure is 
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shared by different pathological deposits in spite of the fact that each disease involves a 
different protein or peptide as the main component of the aggregates. Those various 
proteins, all soluble in their native form, lack common features in primary amino acid 
sequence and range from globular proteins or protein fragments to natively unfolded 
proteins. Since the majority of pathological conditions are associated with the formation 
of amyloid fibers, often the main focus is on these ordered aggregates even though 
there are a number of diseases that involve non-fibrillar amorphous deposits (e.g. 
inclusion body myositis, cataracts). 
In spite of its great significance, little is known about the exact mechanism of 
amyloid formation and the underlying cause of the clinical symptoms associated with 
the different pathological conditions. The process of amyloidosis is extremely complex 
and probably differs from type to type.  However, it is widely accepted that in at least the 
majority of the cases, the amyloid aggregation is triggered by the accumulation of partly 
folded intermediates (Chiti and Dobson, 2006).  Most importantly, for the majority of the 
deposition diseases, old age is considered a major risk factor. Some familiar amyloid 
diseases originate as a result of genetic mutation in the disease-related protein, others 
as a result of aberrant or incomplete proteolysis. In sporadic amyloid diseases, which 
constitute the majority of the protein deposition diseases, the proteins involved have the 
correct wild type sequence and the aggregation occurs due to changes in the cellular 
environment (Dobson, 2003).  The prion diseases are unique since they can be 
transmitted by ingestion of pre-formed aggregates through a seeding mechanism 
(Prusiner, 1997). 
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In general, it is believed that fiber formation happens through a “nucleated growth 
mechanism” (Merlini and Bellotti, 2003) characterized by a lag phase followed by an 
exponential growth. The assembly process involves soluble, low-molecular-weight 
oligomeric precursors, the so called prefibrillar aggregates or protofibrils. The prefibrillar 
species can have different morphologies; they can form non-fibrillar spherical beads, 
amorphous small aggregates, and ring-shaped structures, although all seem to be 
enriched in β-sheet structures (Stefani and Dobson, 2003).  Contrary to the original 
belief, which assumed that the mature amyloid fibrils are the toxic species, recent data 
suggest that the early aggregates are the major pathogenic species, at least in case of 
the neurodegenerative diseases. The toxicity is attributed to the ability of amyloid 
aggregates to interact with cellular components including membranes. Since the mature 
fibers are usually inert, it was even suggested that amyloid formation can be considered 
a protective mechanism used by cells to sequester the toxic small aggregates (Dobson, 
2003; Chiti and Dobson, 2006). Nevertheless, in systemic disorders that are known to 
involve accumulation of large quantities of amyloid deposits (even kilograms), the 
pathological conditions can arise simply due to physical disruption of the affected 
tissues and organs (Merlini and Westermark, 2004).  
Generic nature of protein aggregation 
Amorphous and globular aggregates formed during recombinant protein 
production in bacteria and during in vitro refolding experiments, or thermal aggregation, 
are considered distinct from the highly ordered amyloid fibrils, although both are 
enriched β-sheet structures. It has been shown that some inclusion bodies and thermal 
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aggregates are able to bind the dyes typically used for detection of amyloid fibers 
(Goloubinoff et al., 1999; Ismail et al., 1992).  
In general the ability to form both amyloid-like or amorphous aggregates is not 
restricted to the few proteins associated with clinical disorders, but is also observed in 
case of other non-disease related proteins under specific in vitro conditions (which 
destabilize the native state) (Fandrich et al., 2001; Stefani and Dobson, 2003).  
Recently, it has been proposed that the ability to form aggregates is a generic feature of 
the polypeptide chains that is rooted in the intrinsic physico-chemical properties of each 
polypeptide backbone (Dobson, 1999). Also, the same forces that determine globular 
protein structures also favor aggregation. However, the conditions under which a protein 
can be converted to this alternative conformation still depend on the properties of the 
individual polypeptide (amino acid composition and primary sequence). Indeed, it has 
been shown that hydrophobicity, secondary structure propensities and net charge of the 
protein sequences involved, are all playing and important role in the aggregation 
process. Aggregation is favored when the polypeptide sequence has high 
hydrophobicity, enhanced propensity for β-sheet formation and a low net charge (Chiti 
and Dobson, 2006; Chiti et al., 2003). Thus, while the amyloid structure is an extremely 
stable alternative conformation available to polypeptides, under normal physiological 
conditions the native conformation is still favored over the amyloid form.  
Protein sequences evolved to minimize aggregation 
It is widely accepted that protein sequences have evolved not only to generate a 
wide array of specific biological functions but also to avoid unwanted aggregation 
(Dobson, 2002). Sequences of intrinsically unfolded proteins provide an excellent 
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example of how evolution managed to produce proteins that are devoid of tertiary 
structure under physiological conditions and yet soluble.  These proteins, when 
compared to folded proteins, possess higher net charge and lower overall 
hydrophobicity (Uversky, 2002).  
Computer analysis of protein databases indicated that clusters of consecutive 
hydrophobic residues (Schwartz et al., 2001), but also alternating patterns of 
hydrophobic and hydrophilic residues (known to promote β-sheet formation like the 
ones in amyloid fibers) occur less frequently in naturally occurring protein sequences  
than it would be expected on a random basis (Broome and Hecht, 2000). It is 
undisputable though that both hydrophobic interactions and β-structures are major 
determinants of the native folds and globular structures.  
It has been found that in general short aggregation-prone sequences occur often 
in globular proteins; however they are found more often in prokaryotes than in 
eukaryotes (Rousseau et al., 2006). Interestingly, the lower percentage of aggregation-
prone residues in eukaryotic proteomes correlates with the higher prevalence of 
intrinsically unfolded proteins (characterized by lower aggregation propensity) in these 
systems. Since aggregation-prone sequences cannot be eliminated altogether, their 
subsequent aggregation is minimized by the so called gatekeeper residues.  Thus 
strongly aggregating sequences across proteomes are often capped by prolines and 
glycines, but also by positively charged residues like lysine and arginine, which oppose 
aggregation (Rousseau et al., 2006; Otzen et al., 2000; Parrini et al., 2005).  
Moreover, it has been also shown that the edges of different β-structures found in 
native structures are protected by “negative design” (i.e. contain strategically placed 
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charged residues, prolines, or β-bulges, are short or covered with loops or α-helices) in 
order to avoid unwanted intermolecular interaction between the β-sheet edges 
(Richardson and Richardson, 2002).  
The charge of the residues is also a key parameter in modulating aggregation. It 
has been noted that the net charge of the overwhelming majority of native, folded 
proteins is within a narrow range (-10 to +10) (Lawrence et al., 2007). In general a net 
charge close to zero favors aggregation, but interestingly a large number of proteins 
with opposite net charges could also be aggregation-prone (Konno, 2001; Goers et al., 
2003).  Finally, as expected, there seems to be an evolutionary link between the 
aggregation propensities of polypeptide sequences and the expression levels of the 
corresponding genes. Indeed, it has been shown recently that a lower expression level 
of several human genes corresponds to a higher aggregation propensity of the protein 
(Tartaglia et al., 2007). This observation, although not unexpected, emphasizes the role 
of the cellular environment during the careful selection of protein sequences. The 
authors make an interesting point that the sequences are finely “tuned“ to stay soluble 
at a concentration that is required for the proper functioning of an organism, and there is 
no point for further perfecting those sequences (Tartaglia et al., 2007).   
In summary, in a correctly functioning living organism, proteins are able to avoid 
aggregation and to fold into biologically active native forms in a well controlled cellular 
environment.  This remarkable achievement can be attributed in part to the careful 
evolutionary selection of protein sequences, but also to the evolution of protein quality 
control network.  
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Molecular chaperones  
In an attempt to keep the protein folding process under control and to prevent 
accumulation of  harmful protein aggregates, all living systems developed  quality 
control networks composed of molecular chaperones and proteases.  Whereas 
molecular chaperones enhance the efficiency of de novo protein folding and promote 
reactivation of misfolded proteins, energy-dependent proteases are responsible for the 
degradation of irreversibly damaged, unsalvageable proteins (Lee and Tsai, 2005). As 
the prevalence of the protein deposition diseases illustrates, under certain extreme 
conditions the crucial safeguarding capability of the quality control system can be 
overwhelmed by the large amount of misfolded proteins. However, under physiological 
conditions the combined effects of these powerful tools ensure regular cell function and 
viability. Moreover, since protein misfolding is more likely to occur after heat shock and 
other cellular stress, the expression of molecular chaperones and proteases is 
increased transiently following various stress conditions. This sharp increase in the 
synthesis of a small set of proteins, the so called heat-shock proteins (Hsps), combined 
with a concomitant decrease in the synthesis of the rest of the cellular proteins is due to 
the activation of the heat-shock response (Smith et al., 1998; Lindquist, 1986).  
A quite large and diverse group of proteins are known to function as molecular 
chaperones. The major evolutionarily conserved chaperone families, sorted according 
to the approximate molecular weight of the family members (in kDa) are the small heat-
shock proteins (small Hsps), Hsp 40, Hsp60, Hsp70, Hsp90 and Hsp100 families. Often 
the chaperones are further divided based on their mode of action as “holders” and 
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“folders” (sometimes unfolders) (Dougan et al., 2002). Although in general they are 
known to recognize exposed hydrophobic regions in misfolded protein or folding 
intermediates, the individual chaperone families employ different mechanisms to ensure 
productive folding. For the most part, the different chaperone families and their functions 
are well characterized in bacterial systems. In higher organisms the homologous family 
members are more diverse and can be located in different cellular compartments (Fink, 
1999).   
Small Hsps (IbpA/IbpB in E. coli) are considered “holder” chaperones that form 
large oligomeric assemblies and bind non-native proteins at their surface. Thus they are 
able to passively prevent aggregation by transiently shielding the aggregation-prone 
regions, but they are unable to reactivate misfolded proteins (Fink, 1999).  The refolding 
of the bound proteins requires assistance of other chaperones. Indeed, it has been 
shown that sHsps often cooperate with the ATP-dependent chaperones like Hsp70 and 
Hsp100 (Mogk et al., 2003a; Haslbeck et al., 2005). As opposed to the passive holding 
activity of sHsp family members, “folder” chaperones, like Hsp60 and Hsp70 are able to 
actively promote reactivation of misfolded proteins in an ATP-dependent manner.  
The Hsp60 family member from E. coli, GroEL, also referred to as chaperonin, is 
the best described of all chaperones and provides a unique window into the intricate 
mechanism used by molecular chaperones. GroEL forms a large barrel-shaped 
complex, consisting of two back-to-back stacked rings, the central cavity of which 
recognizes and binds non-native substrates. Folding of the GroEL-bound polypeptide 
occurs inside of the enclosed chamber formed upon additional binding of ATP and the 
lid-like cochaperonin GroES. The lifetime of this complex is controlled by ATP 
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hydrolysis, as both the GroES and the encapsulated polypeptide are released upon 
ATP hydrolysis. Depending on substrates, multiple binding and release cycles may be 
necessary to achieve the correct native fold (Bukau and Horwich, 1998; Horwich, 2002). 
Hsp70 is a very large family of chaperones, with most organisms containing 
multiple isoforms. Besides having a major role in protein folding, Hsp70 family members 
are involved in several other cellular functions like membrane translocation of secretory 
and organellar proteins, control of regulatory proteins like transcription factors (Fink, 
1999). Just as in case of Hsp60s the best understood of the different Hsp70 members is 
DnaK from E. coli.  
DnaK is composed of an N-terminal nucleotide-binding domain (ATPase domain) 
and a substrate-binding domain connected by a short linker.  The C-terminal substrate-
binding domain is composed of two sub-domains: a β-sandwich sub-domain that forms 
the substrate binding cleft, and a flexible α-helical region. Small hydrophobic segments 
exposed by non-native proteins interact with the β-sandwich sub-domain in an extended 
conformation, while the α-helical region functions as a lid and can open or close the 
substrate binding pocket. The movement of the lid is determined by the nucleotide state 
of DnaK. When ATP is bound to the nucleotide-binding domain the substrate-binding 
pocket is open and DnaK has low affinity for substrate. In the ADP-bound state the lid is 
closed over the substrate and DnaK has an increased affinity for the substrate. Two 
additional proteins regulate the cycling of DnaK between the low and the high affinity 
states: the Hsp40 cochaperone DnaJ and a nucleotide exchange factor, GrpE. DnaJ 
binds to the ATPase domain of DnaK and triggers ATP hydrolysis but it can also recruit 
substrates to DnaK, whereas GrpE mediates substrate release by catalyzing ADP 
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exchange to ATP (Bukau and Horwich, 1998; Mayer and Bukau, 2005; Hartl and Hayer-
Hartl, 2002).  The above described functional cycle suggests that the repeated binding 
and release of the misfolded proteins by the DnaK chaperone system 
(DnaK/DnaJ/GrpE) facilitates folding to the native conformation. However, the exact 
mechanism is still not elucidated although several models were proposed to explain the 
folding or refolding activity DnaK (Goloubinoff and De Los, 2007).   
GroEL/GroES chaperonin and the DnaK system are perhaps the two best known 
and described examples of “conventional”  chaperone systems that play a crucial role in 
preventing aggregation by facilitating folding of the newly synthesized proteins (co-and-
posttranslatianally) and active refolding of the misfolded proteins. 
For a long time it was thought that once misfolded proteins accumulate and start 
to aggregate the process is irreversible and those proteins cannot be reactivated. 
However, a milestone discovery by Lindquist and co-workers disproved this belief by 
showing that the large aggregates formed in yeast cells as a result of a non-lethal heat 
shock can be resolubilized and, most importantly, reactivated. These remarkable 
properties were observed only in S. cerevisiae cells expressing a major thermotolerance 
conferring protein named Hsp104, a member of the Hsp100 protein family (Parsell et 
al., 1994; Sanchez and Lindquist, 1990; Sanchez et al., 1992). Further in vitro studies 
demonstrated that Hsp104 in cooperation with the Hsp70 chaperone system from yeast 
(Ssa1 and Ydj1) is capable to dissociate and fully reactivate aggregated proteins 
(Glover and Lindquist, 1998) (also see Fig. 1.1).   
Soon after the discovery of this bi-chaperone system in yeast, it was revealed 
that the bacterial homolog ClpB and the DnaK/DnaJ/GrpE system cooperate during the 
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disaggregation and reactivation of aggregates substrates (Zolkiewski, 1999; Goloubinoff 
et al., 1999; Motohashi et al., 1999). Surprisingly, ClpB/Hsp104 is found only in bacteria, 
plants and fungi.  
AAA+ family of ATPases 
The E. coli molecular chaperone ClpB (as well as the yeast Hsp104) belongs to 
the Hsp100/Clp subgroup of the broader AAA+ superfamily of ATPases associated with 
various cellular activities (Neuwald et al., 1999). AAA+ ATPases are a large group of 
proteins, often described as “molecular machines“, which use the energy from ATP 
hydrolysis to induce conformational changes on macromolecular target substrates. This 
activity is at the center of many important biological processes. Indeed, as their name 
suggests AAA+ family members play an essential role in cellular processes as diverse 
as: protein quality control, membrane fusion and vesicular transport, organelle 
biogenesis, cytoskeletal regulation and DNA replication, repair and transcription 
regulation (Ogura and Wilkinson, 2001).  The unifying feature of AAA+ family members 
is a structurally conserved 230-250 residue-long ATP-binding domain, named AAA+ 
module, with signature Walker A (GxxxxGK[T/S], x= any residue), Walker B (hhhhDE, 
h=hydrophobic residue), sensor-1 (T/N), arginine finger and sensor-2 (R/K) sequence 
motifs. This common AAA+ domain is built up from a core ATPase domain with the 
characteristic α/β Rossman fold and a smaller C-terminal mostly α-helical region. Based 
on the number of the AAA+ modules, AAA+ ATPases are further divided in class I and 
class II members. Class I ATPases contain two conserved AAA+ modules, while class I 
ATPases have only one. The attachment of various extra domains before or between 
the AAA+ modules, as well as interactions with different adaptor or partner proteins, 
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contributes to the structural and functional diversity of the AAA+ family members. 
Generally, AAA+ ATPases assemble into ring-or cylinder-shaped oligomers, mostly 
hexamers, with a narrow channel located at the center and with the nucleotide-binding 
sites located at the interfaces between subunits (Hanson and Whiteheart, 2005; 
Neuwald et al., 1999). 
ClpB structural organization  
ClpB is often described best, both structurally and functionally, when compared 
to the other well known bacterial Clp ATPases. In E. coli, the closest sequence 
homologs of ClpB are: ClpA, ClpX and HslU.  Among them, from the structural point of 
view ClpB is more similar to ClpA, as they are both class I AAA+ members and contain 
a tandem repeat of two AAA+ modules, while ClpX and HslU belong to class II and 
contain only one AAA+ module (Fig. 1.2).  However, only ClpB takes part in protein 
disaggregation, the other homologs function in protein degradation (Zolkiewski, 2006).  
ClpB is a 95 kDa protein that, aside from the two nucleotide binding AAA+ 
domains (AAA-1 or D1 and AAA-2 or D2), contains an N-terminal domain as well as a 
quite large and unique middle domain (M domain) that links D1 to D2 (Fig. 1.2). The 
other three homologous Clp ATPases also possess additional domains either at the N-
terminus, as in case of ClpA and ClpX, or as is the case of HslU, inserted into the AAA+ 
module. These accessory domains are involved in binding adaptor or partner proteins, 
and in recognition of substrates. 
The recently solved crystal structure of the Thermus thermophilus  ClpB (Lee et 
al., 2003) in the presence of a nonhydrolyzable ATP analog confirmed that each of the 
two AAA+ modules assume the conserved three-dimensional fold characteristic to 
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AAA+ ATPases, with the nucleotide binding site enclosed between the large α/β 
Rossman fold (D1-large; D2-large) and the small α-helical domain (D1-small; D2-small). 
It also showed that the N-domain is located on top of the AAA+ modules and is highly 
mobile. But most importantly, the structure revealed for the first time that the middle 
domain inserted into the first AAA+ module forms a long and mobile coiled coil (Fig. 
1.3). 
As bona fide AAA+ family members, the bacterial Clp ATPases including ClpB 
function as hexameric ring-shaped oligomers. Biochemical techniques like gel filtration 
and analytical untracentrifugation as well as imaging with TEM confirmed that ClpB in 
the presence of nucleotides forms hexameric ring-shaped oligomers (Zolkiewski et al., 
1999; Akoev et al., 2004). However, high-resolution structural information is not 
available for the functionally relevant hexameric ClpB. In fact HslU is the only Clp 
ATPase that was successfully crystallized as a hexamer (Bochtler et al., 2000; Sousa et 
al., 2000). 
The hexameric model of T. thermophilus ClpB was built based on the cryoEM 
image of the ClpB hexamer and the crystal structure of the ClpB monomer. This model 
further revealed that the D1 and D2 are oriented head-to-tail and give rise to the 
characteristic double ring structure with the narrow central pore. The inside of the 
channel defined by this pore is lined by the large sub-domains of D1 and D2, while the 
small sub-domains and located on the outside of the hexamer. Interestingly, the unique 
middle domains protrude axially from the outer surface of the oligomeric ring and thus 
resemble the shape of a “two-bladed propeller” (Lee et al., 2003; Lee et al., 2004). 
Although, this first reconstruction does not include the N-terminal domains, based on a 
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yet another hexameric model of ClpB (Diemand and Lupas, 2006) the N-terminal 
domains occupy the top of the double-ringed cylinder and thus surround the central 
pore  (Fig. 1.4). 
Mechanism of ClpB-mediated protein disaggregation 
Even with structural information and extensive biochemical characterization at 
hand, the mechanism of ClpB mediated protein disaggregation is not fully understood. 
Recent evidence suggests that the mechanism of ClpB-mediated protein disaggregation 
involves unfolding of substrate proteins through ATP-dependent translocation across 
the narrow central channel of the ClpB oligomeric ring (Weibezahn et al., 2004). This 
threading mechanism is similar to the mechanism employed by the homologous Clp 
ATPases that function as regulatory particles of proteasome–like proteolytic systems. 
These hexameric ring-forming Clp ATPases (ClpA, ClpX and HslU) associate with the 
large barrel-shaped multimeric peptidases (ClpP and HslV) and control the passage of 
carefully selected substrates to the interior of the proteolytic chamber where 
degradation occurs in a secluded environment (Sauer et al., 2004; Mogk et al., 2004). 
The central channel of Clp ATPases as well as the entry portal into the peptidase 
chamber are too narrow to allow passage of native folded proteins. This implies that 
proteins destined for degradation are able to reach the active sites of the peptidase 
chamber only through the coaxially associated channel of the ring-shaped ATPases and 
only in an unfolded form. Indeed, it has been directly demonstrated that both ClpA and 
ClpX are able to completely unfold and translocate stable folded substrates directly to 
the associated ClpP peptidase for degradation (Weber-Ban et al., 1999; Singh et al., 
2000; Reid et al., 2001).  The translocation of polypeptides through the central channel 
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is facilitated by the ATP-binding and hydrolysis induced conformational changes of the 
oligomeric rings. Unstructured loops located inside of the narrow channel have been 
identified in many AAA+ proteins, and it is suggested that nucleotide-dependent 
movements of these loops may be enough to drive translocation (Hinnerwisch et al., 
2005; DeLaBarre and Brunger, 2005; Wang et al., 2001). 
These proteolytic systems provided a convenient set-up for testing the threading 
mechanism of ClpB. Although ClpB shares the basic ring-shaped architecture of ClpX 
and ClpA, ClpB is unable to interact with the ClpP peptidase since it is missing a 
conserved tripeptide that is known to facilitate such interaction. However, Bukau and co-
workers engineered a ClpA-like ClpB variant, referred to as BAP, simply by replacing a 
helix-loop-helix loop motif located on the bottom surface of the ClpB oligomers with the 
corresponding region from ClpA that contains the conserved tripeptide essential for 
ClpP recognition (Weibezahn et al., 2004). Subsequently, the BAP variant of ClpB was 
able to associate with ClpP and moreover the resulting complex was proteolytically 
active. Thus the BAP-ClpP complex efficiently degraded soluble ClpB substrates but 
also aggregated proteins (Fig. 1.5). However, degradation of aggregated proteins 
required the additional presence of the DnaK system.  Additionally, these experiments 
showed that the disaggregation and the degradation of a model aggregated substrate 
by the DnaK/BAP/ClpP are kinetically coupled events. Previous experiments confirmed 
that the disaggregation and the reactivation of model substrates also occur with similar 
kinetics during the ClpB/DnaK–mediated disaggregation (Schlieker et al., 2004a). Both 
observations are in agreement with the threading model of protein disaggregation, and 
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also emphasize that the continuous extraction of single polypeptides is coupled with 
their forced unfolding by translocation through the ClpB channel. 
Cooperation of ClpB with the DnaK system 
The experiment with the BAP variant of ClpB clearly demonstrated that the 
substrate threading through the narrow central pore of the oligomeric ClpB is an integral 
part of the disaggregation process. While this represents a major progress towards the 
understanding of the unique mechanism of disaggregation, it is only one piece of the 
puzzle. Clearly, the cooperation of ClpB with the DnaK chaperone system has an 
important, but so far not clearly defined role in protein solubilization. The fact that 
degradation of aggregated proteins by the BAP/ClpP complex still remains dependent 
on the DnaK system, while unfolded model ClpB substrates are successfully degraded 
by the same complex, implies that the DnaK system acts during the first steps of the 
disaggregation process, before substrate threading takes place (Weibezahn et al., 
2004). Indeed, recent data confirmed that while unfolded substrates are able to bind to 
conserved channel loops that define the entrance to the ClpB channel, interaction of 
aggregated proteins with this site is observed only in presence of the DnaK system. 
Thus DnaK system might somehow facilitate the extraction of single polypeptide chains 
from the large aggregates and their insertion into the ClpB threading channel (Schlieker 
et al., 2004b; Haslberger et al., 2007).  
This still does not rule out an additional role downstream of the translocation 
step; DnaK could take over the translocated proteins after their exit from the ClpB 
channel and might facilitate their refolding. It has been also noted that functional 
cooperation between ClpB and DnaK system occurs only between chaperones from the 
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same species, as the yeast Hsp104 is not able to cooperate with the bacterial DnaK 
system, and vice versa (Glover and Lindquist, 1998; Krzewska et al., 2001). This 
specificity of function points to a simultaneous action of the bi-chaperone system during 
the disaggregation process.  
ClpB middle domain function 
Another piece of the puzzle is the role of the middle domain (M domain) of ClpB 
in the disaggregation process. This ~120 amino-acid long domain forms the mobile 
coiled-coil structure that is located on the outer surface of the ClpB oligomeric ring, 
adjacent to the first AAA+ domain (Fig. 1.4). These propeller like domains are not only 
mobile in AMPPNP (adenosine 5`-(β,γ-imido)triphosphate)-bound state, but additionally 
they undergo large conformational changes during the different cycles of ATP binding 
and hydrolysis (Lee et al., 2003; Lee et al., 2007). The presence of this unique middle 
domain is the most important fingerprint of the ClpB structure. Indeed, the closely 
related ClpA is missing this domain and is still able to drive protein translocation and 
unfolding across its central channel. This suggests that perhaps this domain is not 
required for the basal translocation activity. However, when the M domains are deleted 
(Kedzierska et al., 2003; Mogk et al., 2003b) or their mobility is restricted (Lee et al., 
2003), ClpB loses the ability to disaggregate proteins. The presence of the mobile M 
domain led to the formulation of yet another mechanism for ClpB-mediated protein 
disaggreagation. Besides the threading mechanism, it was proposed that the mobile M 
domains could pry apart the large protein aggregates or remodel their surface by a 
“crowbar” mechanism (Glover and Lindquist, 1998; Lee et al., 2003). So far there is no 
direct experimental evidence that would confirm such a mechanism. Due to their 
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positioning, M domains (located in close proximity to the large D1 sub-domain of the 
neighboring subunit) were proposed to facilitate nucleotide-dependent cooperative 
conformational changes in the ClpB hexameric ring (Lee et al., 2007).  
Recent work that followed the effect of conserved single amino acid mutations 
within the M domain of ClpB, found that the M domain mutants were defective in 
activities that require assistance from the DnaK system, such as interaction of 
substrates with the ClpB pore sites and disaggregation of aggregated proteins. 
Accordingly, it was proposed that the M domains coordinate the cooperation of the ClpB 
and the DnaK chaperone systems, and are required for the efficient delivery of 
substrates to the central channel of the oligomeric ring (Haslberger et al., 2007). So far, 
attempts to detect a direct interaction between DnaK and ClpB failed.  
ClpB N-terminal domain function 
Thus the M domain of ClpB is a major contributor to the unique chaperone 
activity of ClpB, but also truly exemplifies how adding an attachment domain to an 
otherwise conserved core threading machine can achieve functional diversity. The N-
terminal domain of ClpB is the other attachment domain that could contribute to the 
specificity of ClpB. However, the role of the N-terminal domain of ClpB is not fully 
understood and the experimental data available so far is controversial. Some reports 
indicated that the N-terminal domain of ClpB is dispensable for the in vitro protein 
disaggregation activity (Mogk et al., 2003b; Beinker et al., 2002) or for the development 
of thermotolerance in vivo (Clarke and Eriksson, 2000). At the same time other 
published reports have pointed out that this domain is relevant for ClpB activity, as the 
deletion of this domain, or single amino acid substitutions in the N-terminal domain 
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greatly influenced the disaggregation activity of ClpB as well as substrate binding and 
stimulation of ATPase activity by model substrates (Park et al., 1993; Barnett et al., 
2000; Li and Sha, 2003; Liu et al., 2002; Tanaka et al., 2004).   
Interestingly, a truncated version of ClpB that is lacking the whole N-terminal 
domain of the full-length ClpB is also produced in vivo (Park et al., 1993; Squires et al., 
1991). The biological significance of production of two ClpB isoforms constitutes 
another mystery.  
Even prior to the availability of a high resolution structure for ClpB, it was shown 
that the 149 amino acid-long N-terminal region of ClpB behaves as an independently 
folded stable domain that does not form strong contacts with the ClpB core AAA+ 
domains (Tek and Zolkiewski, 2002). The crystal structure of T. thermophilus ClpB 
revealed that the highly mobile N-terminal domains are connected to the first AAA+ 
domain through a short flexible linker and possess a surprisingly large degree of 
rotational freedom (Lee et al., 2003) ( Fig. 1.3). The functional advantage of having such 
mobile domains located on top of the AAA+ core domains remains to be elucidated. It 
has been proposed that the N-terminal domains might play a role in controlling 
substrate specificity of ClpB and providing additional substrate binding sites (Barnett et 
al., 2000; Li and Sha, 2003; Barnett et al., 2005; Liu et al., 2002).  
Mechanism of substrate recognition by ClpB 
Although ClpB employs a similar translocation mechanism as the closely related 
Clp ATPases, they recognize different substrates: ClpB recognizes aggregated 
substrates while ClpA, ClpX and HslU recognize irreversibly damaged or misfolded 
proteins.  While most proteins destined for degradation are tagged with specific 
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recognition signals, aggregated proteins are not tagged, but they are expected to 
contain a specific blend of amino acids on their surface that is not observed in native 
proteins. Although no such “disaggregation signal” was identified on aggregated 
proteins, peptide-binding studies indicated that ClpB binds preferentially to positively 
charged residues (Lys, Arg), and to a lower extent to aromatic residues (Phe,Tyr,Trp) 
(Schlieker et al., 2004b). The same peptide-binding studies indicated that the central 
pore that defines the entrance to the ClpB translocation channel (located in the first 
AAA+ domain) binds to the model peptide substrates. In particular, three residues, a 
tyrosine and two glutamic acids, were identified to support substrate binding to ClpB. 
However, these residues are located on the flexible loops that line the central pore and 
are conserved in many AAA+ ATPases that do not take part in protein disaggregation 
(Zolkiewski, 2006). Also as mentioned before, aggregated substrates are able to bind 
these loop regions only with help from the DnaK system. Thus the conserved residues 
may not be directly involved in the initial step of substrate recognition, instead they most 
probably play an important role in initiating the substrate threading through the central 
channel.  The N-terminal domain of ClpB is a main candidate for the location of the 
substrate recognition sites. Indeed, recent results from our lab indicate that conserved 
residues from this region support binding of aggregated substrates (Barnett et al., 
2005). 
Goals of current research 
The availability of a high resolution crystal structure of ClpB and the direct 
demonstration of the threading mechanism greatly enhanced our understanding of the 
unique aggregation reversing capability of the ClpB-DnaK chaperone system. However, 
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several major questions still remain unanswered. The majority of those questions are 
related to the initial steps of the disaggregation process, namely substrate recognition, 
binding and initiation of substrate threading, as well as the role of the DnaK chaperone 
system and the ClpB “attachment” domains throughout these processes.  
The overall goal of current research was to gain a better understanding of the E. 
coli ClpB and of the unique process of protein solubilization and reactivation assisted by 
this chaperone. Throughout this work several aspects related to the structure and 
function of ClpB were investigated. Major emphasis was placed on the functional 
interplay between the two naturally occurring isoforms of ClpB during the disaggregation 
process.   
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Figures 
 
Figure 1.1   Model of protein folding and aggregation. 
Partly folded intermediates can be populated during de novo protein folding or upon 
stress-induced unfolding of native proteins. The partly folded intermediates have a high 
tendency to associate with each other and form aggregates that have low solubility. 
Classical molecular chaperones (like GroEL/ES and DnaK in bacteria) promote 
productive folding and prevent aggregation. Chaperones from Hsp100 family are able to 
revere the aggregation process.  
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Figure 1.2   Domain organization of major bacterial Clp ATPases. 
ClpB and ClpA contain two conserved  AAA+ modules (AAA-1 and AAA-2) while ClpX 
and HslU (ClpY) contain only one AAA+ module that resembles the second AAA+ 
module of ClpA and ClpB. The less-conserved N-terminal (N) domains and the unique 
middle domain of ClpB (M), as well as the insertion domain of HslU  (I) are also shown. 
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Figure 1.3   Crystal structure of ClpB from Thermus thermophilus. 
The ribbon drawing of the ClpB monomer (PDB code: 1qvr) (Lee et al., 2003). The N-
terminal domain is located on top of the AAA+ modules (ND, colored in green), the large 
α/β (D1-large, D2-large) and the small α-helical (D1-small, D2-small) sub-domains of 
the conserved AAA+ modules are shown in orange and magenta, respectively. The 
unique coiled coil middle domain (MD) is inserted into the small sub-domain of the first 
AAA+ module (D1-small) and is shown in blue. AMPPNP is shown as CPK model. 
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Figure 1.4   Hexameric model of Thermus thermophilus ClpB. 
Side-view (A) and top-view (B) of the  hexameric model of ClpB is colored by subunits (Diemand and Lupas, 2006). The 
two AAA+ domains are oriented head-to-tail (A) and form the core of the oligomeric ring and define the narrow central 
channel (B). The N-terminal domains are located on top of the double-ringed cylinder right above the first AAA+ modules 
(A) and surround the channel entrance. The coiled coil middle domains protrude axially from the outer surface of the 
oligomeric ring and resemble the shape of a two-bladed propeller. 
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Figure 1.5   Threading model of the ClpB-mediated protein disaggregation. 
Left side: set up used by Bukau and coworkers (Weibezahn et al., 2004) for the 
demonstration of the threading mechanism of ClpB. An engineered ClpB with a ClpA-
like ClpP binding loop (BAP) associated with the ClpP peptidase and degraded 
aggregated substrates in additional presence of DnaK/DnaJ/GrpE (KJE). Right side: 
Mechanism of ClpB-mediated protein disaggregation involves extraction of single 
polypeptides from aggregates and their unfolding by ATP-dependent 
translocation/threading across the narrow central channel of the ClpB oligomeric ring. 
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CHAPTER 2 - Homology modeling of E. coli ClpB 
 
This part of my research was performed in collaboration with Dr. Maria I. Zavodszky, 
Department of Biochemistry and Molecular Biology, Michigan State University 
 
Introduction 
It is indisputable that the availability of three-dimensional structural information 
greatly benefits the functional characterization of proteins. AAA+ ATPases function as 
large ring-shaped complexes (Neuwald et al., 1999), thus NMR spectroscopy-based 
structure determination is not an option for the proteins belonging to this superfamily. 
Instead, X-ray crystallography was successfully used for the determination of the three-
dimensional structures of many AAA+ family members. These proteins often crystallized 
as monomers or non-physiological oligomers; only very few AAA+ family members 
crystallized in the functionally relevant oligomeric ring form.  
High resolution crystal structures are available for proteins related to ClpB, such 
as the bacterial Clp ATPases  ClpA (PDB code1ksf, (Guo et al., 2002)) and ClpX (PDB 
code 1um8, (Kim and Kim, 2003)) as well as for HslU(ClpY) (PDB code 1do0, (Bochtler 
et al., 2000); PDB code 1q3i, (Sousa et al., 2000)). Among them, only HslU crystallized 
in the hexameric form.  In the case of ClpB, crystal structures were reported for the 
isolated N-terminal domain (PDB code 1khy, (Li and Sha, 2003)) as well as for the large 
sub-domain of the first AAA+ module (D1 large) from E. coli (PDB code1jbk, (Li and 
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Sha, 2002)). Structure of the full-length ClpB is only available for the Thermus 
thermophilus ClpB (PDB code 1qvr, (Lee et al., 2003)). 
 The structure of the isolated N-terminal domain (amino acids 1-148) of E. coli 
ClpB was determined at 1.9 Å resolution (Li and Sha, 2003). The crystallographic 
asymmetric unit contained four identical N-domain monomers, each consisting of eight 
α helices and two small β strands that form a single domain (Fig. 2.1). It was also noted 
that the structure of the N domain possesses a pseudo two-fold symmetry where the 
two sub-domains are connected via a flexible region. The flexible linker region is 
characterized by high temperature factors and, indeed, parts of the linker region were 
not resolved (amino acids 75-81) in the crystal structure. The two structurally similar 
sub-domains correspond to the previously identified sequence repeats in the N-domain 
of the Clp ATPases (Lo et al., 2001). However, the two sequence repeats within the N-
domain do not define separate folding domains.  
The second E. coli ClpB fragment with crystal structure deposited in the Protein 
Data Bank contains the large subunit of the first AAA+ module of ClpB (amino acids 
159-351) (Li and Sha, 2002). This isolated fragment crystallized as a monomer and is 
missing a short, probably disordered segment (between amino acids 287 and 292). This 
structure was solved at 1.8 Å resolution and was found to assume the conserved three-
dimensional α/β Rossmann fold of the AAA+ ATPases (Fig. 2.2). Since the crystallized 
fragment only contains the large D1 subunit and a small part of the first α helix of the 
small D1 subunit, it is not surprising that the crystal structure does not include the bound 
nucleotide. An important feature of the structure is that it contains the conserved pore 
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loop (residues 243-254) known to line the entrance of the channel in the hexameric 
AAA+ rings.  
The crystal structure of the full-length T. thermophilus ClpB in complex with the 
non-hydrolysable ATP analog AMPPNP was solved at 3 Å resolution (Lee et al., 2003). 
Three independent ClpB monomers were identified in the asymmetric unit of the crystal, 
each containing two AMPPNP molecules (one per AAA+ domain). Even though all three 
monomers were present in the same nucleotide-bound state, they were found to 
assume different conformational states in the crystallographic asymmetric unit. 
Superposition of the backbones of the three monomers showed the largest differences 
between the conformations of the N-terminal domains, suggesting these domains are 
highly mobile and can undergo rotational motions up to 120˚ (Fig. 2.3). The crystal 
structures provided several other pieces of useful information regarding domain 
organization of ClpB, as described in the introduction section of this dissertation. 
Interestingly, the non-physiological trimers did not assemble into a complete hexamer, 
instead they formed a helical structure. A hexameric model of T. thermophilus ClpB was 
built by fitting the crystal structure of one of the three representations of the monomeric 
ClpB into the three-dimensional envelope of the ClpB hexameric ring obtained by cryo-
EM (Lee et al., 2003). In this reconstituted hexamer, the subunits are organized in such 
a way that the D1 large sub-domain is positioned right above the D2 large sub-domain 
of the same monomer. However, this hexameric model does not contain the N-terminal 
domains of ClpB, since these domains were not visible in the single-particle 
reconstruction. Also, the conserved pore loops of D1 (residues 235-245) and D2 
(residues 637-650) AAA+ domains, as well as an additional short segment (residues 
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270-290)  are missing from the model since they were not resolved in the crystal 
structure.  
 Recently a new approach was developed  for the modeling of the AAA+ type ring 
complexes from monomeric structures (Diemand and Lupas, 2006).  This semi-
automated modeling procedure relies on structural constraints collected from the atomic 
structures of AAA+ family members that crystallized in the functional oligomeric form, 
and combines this information with sampling algorithm and protein docking until an 
acceptable oligomeric model is reached. This new procedure was used to build a 
hexameric model of the full-length ClpB starting from a monomeric crystal structure 
derived (chain B from 1qvr) from the non-physiological trimer of the T. thermophilus 
ClpB (Lee et al., 2003). This model is also missing the conserved pore loops (Fig. 2.4), 
but includes the N-terminal domains and proposes a different arrangement for the two 
AAA+ rings relative to the previous model. Based on this modeling, a staggered 
arrangement was proposed where the D1 domain of one subunit is above the D2 
domain of the neighboring subunit. However, this model was built by separately docking 
the D1 and D2 domains into hexameric rings before building the characteristic double-
ring structure and as a result the structure contains a chain-discontinuity site at the 
interface of the two rings (residue 543-544) as shown is Fig. 2.4. This procedure is 
available online under iMolTalk server (http://i.moltalk.org/), thus we are going to refer to 
this hexameric model of ClpB (Diemand and Lupas, 2006) as the iMolTalk hexameric 
model. 
 Aside from the structure of the isolated N-terminal domain and the D1 large sub-
domain fragment, there is no high-resolution structure available for the full-length E.coli 
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ClpB. However, the high sequence identity between E. coli ClpB and the T. 
thermophilus and the availability of the crystal structures of the two segments 
mentioned above make E. coli ClpB a good candidate for homology modeling.  
Programs  
Sequences of E. coli ClpB and T. thermophilus ClpB were aligned using the 
BOXSHADE program (www.ch.embnet.org). The percent of identical residues was 
calculated manually. The atomic coordinates of the iMolTalk hexameric model of 
T.thermophilus ClpB were downloaded from http://i.moltalk.org/, while the coordinates of 
the N-terminal domain of E. coli ClpB (PDB code 1khy), the large D1 domain of E. coli 
ClpB (PDB code 1jbk), and of the non-physiological trimer of T.thermophilus ClpB (PDB 
code1qvr) were downloaded from the Protein Data Bank. E. coli ClpB with the NCBI 
accession number P63284 was used as a target sequence for modeling. Target and 
template sequences were aligned by using the ClustalW server (www.ch.embnet.org), 
while PyMOL v0.99 (DeLano Scientific LLC) was used for the visualization of the 3D 
structures. Restraint-based homology modeling was performed using MODELLER 
version 9.1 (Sali and Blundell, 1993; Sali and Overington, 1994; Fiser et al., 2000). This 
program was run on a 64-bit Linux desktop computer with dual Xeon processors. 
Homology modeling with MODELLER 
Comparative or homology modeling is known to give a fairly accurate three-
dimensional model of a target protein if it has at least 30 % sequence identity to the 
template sequence whose atomic structure is available. In general, the quality of the 
model increases with the increasing sequence similarity between the target and 
template, but decreases as the number and the length of the gaps in the aligned 
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sequences increases. A model based on greater than 50% identity usually has about 
90% of the backbone in the right conformation with only some minor errors in loop 
conformations and side-chain packing. The quality of such model is comparable to a 
low-resolution crystal structure (above 3 Å) or a medium-resolution NMR structure (Sali 
and Blundell, 1993). These models proved to be useful, for example, for designing 
mutations to test hypotheses regarding protein function (Muller et al., 2006), 
rationalizing the effects of mutations (Marabotti and Facchiano, 2005), locating binding 
sites (Indarte et al., 2008), identifying the determinants of substrate specificity (Sauder 
et al., 2000), structure-based drug development (Takeda-Shitaka et al., 2004), and 
predicting protein-protein interactions (Davis et al., 2007). 
E. coli ClpB shares 56 % of its sequence with ClpB from T.thermophilus, as 
calculated from the alignment shown in Fig. 2.5. The sequence identity is highest in the 
AAA+ domains and somewhat lower in the N-terminal region and in the M domain. To 
increase the accuracy of the model in regions of lower sequence identity, instead of 
relying solely on the crystal structure of the full-length T. thermophilus ClpB, we also 
included the other two existing crystal structures of the E. coli ClpB fragments as 
templates for the modeling. There are several completely automated web servers 
available to perform homology modeling. However we used the downloaded, command-
line version of MODELLER that allows model building based on multiple template 
structures and ab initio loop modeling. Since all three template crystal structures were 
missing short disordered segments, we performed loop refinement on those segments 
with the automated loop modeling module of MODELLER (Fiser et al., 2000).    
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As the first step in the model building, the E. coli ClpB target sequence was 
aligned with the template sequences. Although MODELLER has its own module  for 
sequence alignment,  we obtained the best results (highest sequence identity and 
fewest gaps) when ClustalW was used to perform pairwise alignments of the target with 
the three template sequences (T. thermophilus full-length sequence; E. coli N-terminal 
domain sequence; E. coli large D1 domain sequence). The pairwise alignments were 
then combined to get the multiple sequence alignment in a PIR database format. 
Further manual adjustments were done to remove the residues from the template 
sequences whose atomic coordinates are not resolved in the crystal structures. 
In addition to the sequence alignment of the target and three templates, the three 
PDB files containing the 3D coodinates of the template atoms were also used as input 
to MODELLER. For the full-length T. thermophilus ClpB, the coordinates of the ClpB 
monomer were extracted from the iMolTalk hexamer. The PDB file containing the D1 
large sub-domain of E. coli ClpB (PDB code 1jbk) was used without modifications, but 
the PDB file that contained the E.coli ClpB N-terminal fragment (PDB code 1khy) was 
modified by retaining the coordinates of only one of the four chains.  
MODELLER builds 3D models of the target sequence by a method that relies on 
the satisfaction of spatial restraints extracted from the template structures, followed by 
an optimization method to minimize the violations of these restraints (Sali and Blundell, 
1993). The resulting models are evaluated and scored. We kept the model of E. coli 
ClpB with the best score (i.e. the lowest value of the MODELLER objective function) for 
further refinement. Since all three template crystal structures were missing short 
segments, we performed loop refinement on those segments with the de novo loop 
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modeling module of MODELLER. This extra step was especially important in order to 
optimize the conformation of the D2 pore loop of ClpB (residues 647-660) since the full-
length T. thermophilus ClpB template structure was missing the conserved pore loops. 
The model of full-length E. coli ClpB monomer with the best score after the loop 
refinement was used to build the hexameric model of the E. coli ClpB. This was done by 
superimposing the model of the monomeric E. coli ClpB over each subunit of the 
iMolTalk hexamer of T. thermophilus ClpB. Optimal packing at the subunit interfaces 
was achieved by full-length backbone superposition, which was performed in PyMOL. 
The coordinates of these superimposed monomers were merged into a hexamer.   
The resulting hexameric model was further optimized by a short (500-step) 
energy minimization. This was done with the CHARMM force field using the 
Generalized Born (GB) solvent model. Following the energy minimization, no major van 
der Waals overlaps were detected at the subunit interfaces. 
Results and Discussion  
The cartoon representation of the final model of the E. coli ClpB in the hexameric 
form is presented in Fig. 2.6. The monomer is shown superimposed over chain A of the 
iMolTalk model of T. thermophilus ClpB in Fig. 2.7. The backbones of the two models 
are in very similar conformations, with a root mean square deviation of 1.96 Å between 
them. The quality of the model was evaluated using the PROCHECK program 
(Laskowski et al., 1993) by generating the Ramachandran plot of backbone phi-psi 
angles. This is a simple and sensitive way to asses the quality of a structural model in 
the absence of experimental data. For a good quality structure, about 90% of the 
residues are expected to lie in the most favorable regions of phi-psi values. The 
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Ramachandran plot of the E. coli ClpB homology model after the energy minimization is 
shown in Fig. 2.8. The final model had more than 88% of the residues in the most 
favorable regions, while another 11% fell into the additionally allowed regions. Only 1% 
of the residues had unfavorable backbone conformations with backbone phi-psi values 
in the disallowed regions (Fig. 2.7 and Fig. 2.8). Unexpectedly, these residues were 
scattered throughout the 3D structure of the monomer and were mainly located in 
various surface loops as shown in Fig. 2.7. For some of the residues the unfavorable 
conformation arises simply because the corresponding residues from the template are 
also in an unfavorable backbone conformation (as for Arg119 and Ala589) or are 
missing from the crystal structure used as a template (as for Lys250 and Asp290). In 
other cases considerable differences between the length and the conformation of short 
regions of the template and the model could be the reason for the unfavorable 
backbone conformation of the residues that fall into the disallowed region of the 
Ramachandram plot (as for Ser45, Asp696, Glu731, Glu768). Ironically this could be 
attributed to the high sequence identity between the E.coli and the T. thermophilus ClpB 
(Fig. 2.5). As the two amino acid sequences have large regions with very high identity 
and only short connecting sequence regions with large differences, the MODELLER 
program tried to fit very closely the regions with high sequence identity; this resulted in 
tension or unfavorable backbone conformation for some phi-psi angles of the residues 
located in the connecting regions that are different in template and query sequence. The 
short energy minimization intended to remove major van der Waals overlaps following 
the model building could not get the residues from the disallowed region over the 
energy barrier to a more favorable conformation. A long molecular dynamics (MD) 
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simulation would be needed to solve this problem, but it would be computationally very 
expensive and time consuming. 
 Overall this hexameric model of E.coli ClpB is a structure of reasonable quality. 
As a comparison, models built from crystal structures solved at least at 2 Å resolution 
and an R-factor of not more than 20%, are expected to have ~ 90% of the residues in 
the most favored regions (Laskowski et al., 1993).   
In our new model of the hexameric E. coli ClpB the D1 and D2 AAA+ domains 
are arranged in a staggered conformation similar to the conformation observed in case 
of the iMolTalk hexameric model (the only full length template structure used for 
modeling) and different from the conformation proposed for the N-terminally truncated 
T. thermophilus hexameric model where the D2 in right below the D1 in each subunit 
(Lee et al., 2003). Staggered arrangement of the two AAA+ rings was also proposed 
previously for the ClpA hexameric model (Guo et al., 2002). 
Compared to the iMolTalk hexamer of T. thermophilus ClpB, our model of the E. 
coli hexamer does not contain the chain-discontinuity at the interface of the two AAA+ 
rings. The other advantage of this model is that the pore loop regions of both the D1 
and D2 AAA+ domains are included in the structure. The conserved Tyr residues, 
Tyr251 and Tyr653 located in the highly flexible pore loops of each of the six subunits 
were shown to directly contact the substrate proteins (Weibezahn et al., 2004). Tyr251 
lines the entrance to the ClpB channel while Tyr653 is located further down in the 
channel. Interestingly, in the hexameric model, the upper six D1 pore loops are not in a 
completely symmetrical arrangement, as shown by the orientation of the six Tyr251 
residues (Fig. 2.9). This is the result of the final refinement and it is in agreement with 
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the fact that these loops are extremely mobile. Indeed, it was proposed that nucleotide-
dependent movements of the flexible loops located inside of the ClpB channel drive 
translocation of substrates through the ClpB channel (Park et al., 2005; Hinnerwisch et 
al., 2005). In our model, it looks like the approximately 14 residue long D2 loops 
(residues 647-660 in each subunit) are in upward positions, very close to the D1 ring 
(Fig. 2.10). It has been suggested previously that ATP hydrolysis by the D2 ATPase 
domain can induce a downward movement of this loop which in turn may drive the 
translocation of the polypeptides through the narrow pore of the oligomer (Hinnerwisch 
et al., 2005).  
Finally, the diameter of the pore at the channel entrance defined by the Tyr251 
residues is approximately 15 Å (measured in PyMOL). This value is consistent with the 
previously published diameter of the nucleotide-bound oligomeric ring approximated 
from the TEM images (Akoev et al., 2004; Lee et al., 2003). The weakness of our model 
is that it does not contain bound nucleotides. The full-length T. thermophilus ClpB 
template contained ATP analogs (AMPPNP), but the structure of the large D1 domain of 
E. coli ClpB was solved without a bound nucleotide. Overall we obtained a good quality 
model of the hexameric full-length E. coli ClpB, which will be useful in designing 
mutants to explore the mechanism of this protein and in interpreting experimental data.  
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Figures 
 
Figure 2.1   Crystal structure of the N-terminal domain of E. coli ClpB. 
Ribbon representation shows the four identical monomers found in the asymmetric unit 
of the crystal (PDB structure 1khy). The four chains are represented in different colors.  
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Figure 2.2   Crystal structure of D1 large sub-domain of E. coli ClpB. 
Ribbon representation of the isolated D1 large sub-domain of E. coli ClpB from PDB 
structure 1jbk colored by secondary structure. The conserved D1 pore loop and the 
Walker A loop (P-loop) are colored in blue and cyan, respectively. The N-terminus and 
C-terminus of the molecule are labeled.  
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Figure 2.3   Superimposed chains of the non-physiological trimer of the T. Thermophilus ClpB. 
Chains A, B, C from the 1qvr structure are colored red, blue and green, respectively. The N-terminal domain is located at 
the top and the C-terminus is at the bottom on panel A. Only the N-terminal domains of the three chains are shown in 
panel B rotated 90 degrees compared to panel A. The N-terminal residues are shown as spheres to illustrate the different 
orientation of the N-terminal domain of chain C relative to chains A and B. 
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Figure 2.4   iMolTalk hexameric model of T. thermophilus ClpB. 
The top view (left) and the side view (right) of the hexamer with each monomer in a different color. The left panel 
illustrates the entrance to the ClpB channel. The mobile D1 loop (residues 235-245) and D2 loop (637-650) are missing 
from each subunit. The arrow in the right panel indicates the chain-discontinuity site between the residues 543-544. 
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Figure 2.5   Sequence alignment of E. coli and T. thermophilus ClpB. 
The sequence of E. coli ClpB (EC_ClpB) and T. thermophilus ClpB (TT_ClpB) was 
aligned using BOXSHADE. The background is black for identical residues and gray for 
similar ones. 
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Figure 2.6   Hexameric model of the E. coli ClpB. 
Panel A: Side-view of the hexameric model of the E. coli ClpB colored by subunits. The 
N-terminal domains are at the top. Panel B: Top-view of the hexameric model of the E. 
coli ClpB colored by subunits. The previously unresolved flexible loops are protruding 
into the central pore. 
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Figure 2.7   Superposition of the E. coli and T. thermophilus ClpB. 
Cartoon representation of the E. coli ClpB homology model (shown in green) 
superimposed over chain A of the T. thermophilus hexameric ClpB model from iMolTalk 
(shown in red). Residues with backbone phi-psi angles in the disallowed regions (Ser45, 
Arg119, Lys250, Asp290, Ala589, Asp696, Glu731, Glu768) are shown as spheres. 
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Figure 2.8   Ramachandran plot. 
The Ramachandran plot of one of the monomers from the final E. coli ClpB hexameric 
model generated with PROCHECK. Three-letter codes and numbers of the residues in 
the disallowed region are shown in red. 
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Figure 2.9   Flexible pore loops in hexameric ClpB. 
Top view of the hexameric model of the E. coli ClpB. Conserved Tyr residues Tyr251 
(red) and Tyr653 (blue) located on the D1 (Tyr251) and D2 (Tyr653) flexible loops inside 
of the ClpB channel.  
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Figure 2.10   Position if the D1 and D2 conserved pore loops. 
Close up side-view of full-length E. coli ClpB monomer model with the D1 and D2 
flexible loops. The conserved Tyr251 of the D1 loop is shown as red sphere, while the 
conserved Tyr653 of the D2 loop is shown in cyan. The large and small sub-domains of 
D1 and D2 are colored in orange and magenta, respectively. The M domain is blue and 
the N domain is green (only parts of the domains are visible). 
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CHAPTER 3 - Domain stability and nucleotide-induced 
conformational changes in ClpB 
 
Introduction 
The ring-shaped oligomeric form and the ATP-dependent remodeling activity, 
attributed to the AAA+ superfamily members, are tightly coupled. This is because the 
nucleotide binding sites are located both between the large and the small sub-domains 
of the AAA+ modules of a given subunit and at the interfaces between the subunits of 
the oligomeric ring. The nucleotide-binding pocket is formed by the conserved Walker A 
and Walker B sequence motifs of the large AAA+ sub-domain. Conserved residues that 
belong to these motifs are required for ATP binding and hydrolysis. Specifically, the 
classical Walker A motif directly interacts with the phosphates of ATP and is also 
refereed to as the phosphate binding loop, or P-loop. Also, the conserved Glu residue of 
the Walker B motif is believed to act as a catalytic base for the hydrolysis reaction, while 
the Asp residue coordinates the Mg2+ required for the ATP hydrolysis. Besides the 
classical Walker motifs AAA+ ATPases contain conserved motifs that “sense” the 
presence or the absence of nucleotides, transmit this information to distal places, and 
coordinate ATP hydrolysis and conformational changes between the subunits of the 
oligomer. Sensor-1 polar residue (N/T) is located between the Walker A and Walker B 
motifs in the 3D structure and interacts both with the Walker B residues and the γ-
phosphate of the bound ATP. Similarly the conserved sensor-2 Arg residues located in 
the small AAA+ sub-domain is positioned so it can directly contact the γ-phosphate of 
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the bound ATP and mediate conformational changes in the small subunit. Finally, the 
“arginine finger“ residue from one subunit of the oligomer contributes to the ATP binding 
site of the neighboring subunit in the oligomer and could transmit the ATP hydrolysis-
driven conformational changes to the neighboring subunit (Ogura and Wilkinson, 2001; 
Neuwald et al., 1999; Hanson and Whiteheart, 2005).  
In case of ClpB, it has been long established that oligomeric ring formation is 
necessary for binding of nucleotides and ATP hydrolysis, which in turn, is necessary for 
the chaperone activity of ClpB (Barnett et al., 2000).  However, besides the functionally 
relevant hexameric ring structure, under certain conditions ClpB is also able to form 
heptameric ring assemblies. Previous work from our lab indicates that in solution, ClpB 
shows a reversible equilibrium between monomers, heptamers, and intermediate-size 
oligomers. High protein concentration or low ionic-strength buffers stabilize heptameric 
ClpB, which switches to a hexamer upon binding of nucleotides (Akoev et al., 2004).  
The functional diversity of AAA+ ATPases appears to rely not only on the 
common protein architecture, but also on similar principles of molecular mechanism. 
Thus, it can be proposed that the mechanism of other AAA+ ATPases might parallel 
that of ClpB and could involve insertion or enclosure of substrates in the central pore of 
the oligomeric ring followed by an ATP-dependent work resulting in a change of 
substrate conformation. 
 To understand that mechanism, it is essential to characterize the conformational 
effects that accompany formation of the AAA+ ring. In particular, it is important to 
understand the role of distinct protein domains within and outside of the AAA+ module 
in maintaining the ring structure. It is also important to identify the conformational 
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changes that occur in the various ClpB domains as a result of ATP binding and 
hydrolysis.  We attempted to reach these goals, by investigating the thermodynamic 
stability of ClpB in the monomeric and oligomeric form and by following the local 
conformational rearrangements in ClpB upon ADP or ATP binding.  
Materials and Methods 
Mutagenesis and protein purification 
Site-directed mutagenesis of ClpB was performed using the QuickChange 
method (Stratagene). Primers were ordered from IDT (Integrated DNA Technologies, 
INC). pET20b+ vector containing the wt ClpB sequence was used as the starting 
template for the PCR reactions. Wt ClpB contains two Trp residues, which were 
mutated to Phe to produce a Trp-less ClpB sequence that was used as template for the 
subsequent Trp mutations. Following digestion of the parental DNA the PCR products 
were transformed into XL1-Blue supercompetent cells (Stratagene). Plasmid DNA was 
purified from overnight cultures using QIAprep Spin Miniprep Kit (Qiagen) and 
sequenced at DNA Sequencing and Genotyping Facility, Department of Plant Pathology 
at KSU. Plasmid DNA containing the desired mutation was transformed into BL21 (DE3) 
cells (Novagen) using the provided protocol. Previously published procedures were 
used to produce and purify Escherichia coli ClpB and its mutants (Barnett et al., 2000).  
Proteins were dialyzed against 50 mM Tris/HCl pH 7.5, 0.2 M KCl, 20 mM MgCl2, 
1 mM EDTA, 1 mM DTT, with 10% glycerol. Protein concentration of ClpB was 
determined spectrophotometrically. The extinction coefficients were recalculated for the 
Trp-mutants. 
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ClpB ATPase assay 
ClpB samples were incubated for 15 min at 37 °C in 100 mM Tris-HCl pH 8, 10 
mM MgCl2, 5 mM ATP, 1 mM EDTA, 1 mM DTT without or with 0.1 mg/ml κ-casein 
(Sigma).  Inorganic phosphate production was determined using the malachite green 
method (Hess and Derr, 1975; Lanzetta et al., 1979). 2.5 μg ClpB was used for the 
basal ATPase measurements and 0.25 μg for the measurement of the κ-casein 
stimulated ATPase activity. Three separate measurements were performed for each 
ClpB variant. 
Urea-induced unfolding of ClpB 
 Solutions containing urea at the concentration 0 - 8 M were prepared with buffer 
F (50 mM Tris/HCl pH 7.5, 20 mM MgCl2, 1 mM EDTA, 1 mM DTT). To investigate 
monomeric ClpB, single-Trp ClpB variants were diluted to 0.1 mg/ml in the buffer F urea 
solutions containing 0.3 M KCl. To investigate heptameric ClpB, the ClpB variants were 
diluted to 0.5 mg/ml in the buffer F urea solutions. The urea concentration in case of 
each sample was corrected for the dilution by the protein solutions. ClpB samples were 
incubated overnight (~15 h) at room temperature before measuring fluorescence 
spectra.  
Fluorescence spectroscopy 
Fluorescence spectra of the single-Trp ClpB variants were measured with a Cary 
Eclipse spectrofluorimeter (Varian) using a 1-cm quartz fluorescence cuvette. The 
excitation wavelength was set at 300 nm and the emission spectrum was recorded from 
280 nm to 450 nm. In case of the unfolding experiments with 0.1 mg/ml ClpB, the 
excitation slit was 5 nm and the emission slit was 10 nm. In experiments with 0.5 mg/ml 
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ClpB, both slits were 5 nm. The spectra of urea-containing buffers (without ClpB) were 
subtracted from the protein spectra. 
For the detection of the nucleotide-induced conformational changes, proteins 
were diluted to 0.6 mg/ml in buffer F. The fluorescence emission spectra were recorded 
in case of each ClpB variant without nucleotides, than ADP or ATP was added from 0.2 
M stock solutions. The final concentration of the nucleotides was 2 mM in order to 
saturate the nucleotide binding sites. Both excitation and emission slits were set to 5 
nm. 
Results and Discussion 
Design and characterization of the Trp variants of ClpB 
Stability of different structural domains, as well as nucleotide-induced 
conformational changes in ClpB, was monitored by following the changes in the intrinsic 
fluorescence of Trp residues. This required the production of several ClpB mutant 
proteins, each with a single Trp residue located in different domains. Aromatic residues 
located in proximity of the structurally or functionally important residues were chosen for 
mutation.  
E. coli ClpB contains two Trp residues: Trp462 at the center of the coiled-coil 
domain (see Fig. 3.1) and Trp543 in the D1 small domain. First, we produced two 
single-Trp variants of ClpB, W543F (with the remaining Trp462) and W462F (with the 
remaining Trp543). Next, we produced a Trp-less ClpB with the double mutation 
W462F/W543F. Subsequently, five new variants of Trp-less ClpB were produced  with a 
single Trp introduced in specific locations containing aromatic residues (see Fig. 3.1): 
F105W (within the N-terminal domain, close to the putative substrate binding site 
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(Barnett et al., 2005)), Y251W (at the D1 entrance to the ClpB channel),  F276W (within 
Walker B motif in D1 large domain), F603W (within Walker A motif in D2 large domain), 
and Y812W (within sensor-2 motif in the D2 small domain). Altogether, we produced 
seven variants of ClpB, each with a single Trp located in each of the six protein domains 
(at positions 105, 251, 276, 462, 543, 603, and 812, see Fig. 3.1). 
After protein production and purification the structural integrity and biochemical 
functionality of the seven single-Trp variants of ClpB was tested. Similar to wt ClpB, the 
seven single-Trp ClpB variants efficiently formed oligomers at high protein 
concentration, as determined by sedimentation velocity studies (data not shown), which 
indicates that the site mutations did not disrupt the structure of the ClpB variants. All 
seven ClpB variants were active ATPases (Fig. 3.2 A). The basal ATPase activity varied 
among the single-Trp variants with three proteins showing lower activity than the wt and 
three proteins showing higher activity. Interestingly, the introduction of a Trp in the 
vicinity of the Walker A motif in D2 (Trp603) significantly activated the ClpB ATPase. 
Casein, an unstructured protein, is often used as an activator of the ATPase activity of 
the wt ClpB. Fig. 3.2B shows that the ATPase of all seven variants of ClpB was 
activated by casein (compare the scale with Fig. 3.2A). The ATPase activity of the ClpB 
variants measured in the presence of casein paralleled their basal activity. We conclude 
that a replacement of the selected aromatic residues (either Phe or Tyr) by Trp may 
modulate the rate of ATP hydrolysis of ClpB. Interestingly, even mutations in the 
domains that do not contain nucleotide binding sites (W105 in the N-terminal domain, 
W462 in the coiled-coil domain) affect the ClpB ATPase, which suggests that concerted 
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conformational changes in all domains may contribute to the ATP-dependent 
functionality of ClpB. 
Domain stability in ClpB 
Thermal unfolding transitions of ClpB by differential scanning calorimetry 
revealed  that ClpB contains multiple folding domains that likely correspond to the 
structural domains identified in Fig. 3.1B (Nagy et al., 2006). We used Trp fluorescence 
to monitor changes in conformation of each domain in ClpB at equilibrium with 
increasing concentrations of urea. It has been previously shown that ~0.1 mg/ml ClpB is 
monomeric in high ionic strength buffers (0.2-0.3 M KCl), whereas heptameric ClpB 
predominates at low ionic strength (Akoev et al., 2004; Zolkiewski et al., 1999). We 
compared the Trp fluorescence spectra of the ClpB variants under the conditions where 
either monomeric (see Fig. 3.3A) or oligomeric ClpB (see Fig. 3.3B) predominates. As 
shown in Fig. 3.3A, the Trp emission intensity and the wavelength position of the 
emission band strongly depend on the position of the fluorophore in monomeric ClpB. In 
particular, the fluorescence of Trp276 (near the D1 ATP binding site) shows the 
strongest intensity quenching, whereas that of Trp543 (in D1 small domain) shows the 
lowest quenching. The differences between emission spectra of different ClpB variants 
indicate that the solvent exposure and the local environment of each of the fluorophores 
are different for each ClpB variant. Importantly, the intensities and positions of Trp 
emission spectra for the oligomeric ClpB (Fig. 3.3B) correlate with those observed for 
monomeric ClpB (Fig. 3.3A). This result indicates that major conformational changes 
are not likely to occur in the ClpB domains during protein oligomerization. 
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To further characterize the effects of ClpB oligomerization on the properties of its 
domains, we investigated the stability of the ClpB variants and measured Trp 
fluorescence as the function of urea concentration. To prevent protein aggregation at 
high temperature, we performed chemical denaturation studies for ClpB at room 
temperature (25 °C). To ensure the thermodynamic equilibrium during protein 
denaturation studies, we incubated ClpB in urea-containing buffer overnight and 
determined that the fluorescence spectra of ClpB samples did not change upon longer 
incubation. We also investigated the urea-induced unfolding of ClpB in the presence of 
ATP and ADP. Interestingly, after prolonged incubation with nucleotides, ClpB solutions 
with low urea concentrations became cloudy, which indicated protein precipitation and 
made fluorescence measurements unfeasible. This result suggests that nucleotides 
induce a high-affinity protein-binding conformation in ClpB and promote its non-specific 
self-association. Indeed, ClpB binds substrates with the highest affinity in its ATP-bound 
state (Weibezahn et al., 2003). 
Fig. 3.4 A-G shows urea-induced changes in the Trp fluorescence intensity of the 
seven ClpB variants under conditions stabilizing the ClpB monomer and the heptamer. 
For all chosen locations of the fluorescence probes in ClpB, except Trp251 and Trp276 
(Fig. 3.4 B and C), the Trp emission intensities decrease as the concentration of urea 
increases and show cooperative urea-dependent transitions. The emission intensities of 
Trp251 and Trp276 are the lowest among all investigated ClpB variants (see Fig. 3.3), 
which indicates that both these locations of the fluorophores are significantly exposed to 
the solvent in the native ClpB. Trp251 is located within a flexible unstructured loop at 
the entrance to the ClpB channel. The Trp251 loop has not been resolved in the crystal 
 71
structure of the T. thermophilus ClpB (Lee et al., 2003) and is involved in binding 
aggregated substrates to ClpB (Barnett et al., 2005; Haslberger et al., 2007). Urea-
induced changes in the fluorescence of Trp251 are small and do not show clear 
cooperative transitions, which is consistent with the lack of stable structure within the 
channel loop either for the monomeric or the oligomeric ClpB. Trp276 is located near 
the conserved acidic residues of the Walker B motif in the D1 large domain of ClpB, 
which are essential for the ATP hydrolysis (Weibezahn et al., 2003). The Walker B motif 
is located at the tip of a β-strand (Lee et al., 2003) and its side chains are exposed into 
the ATP binding site. Unlike for the remaining fluorophore positions, the fluorescence 
intensity of Trp276 increases with increasing concentration of urea (Fig. 3.4C), which 
suggests that urea decreases the emission quenching of the solvent-exposed Trp276. 
Characteristically, the changes in Trp276 fluorescence show similar patterns for the 
monomeric and the oligomeric ClpB. We conclude that Trp251 and Trp276 are highly 
exposed to the solvent in the ClpB structure and their emission intensities may not 
follow the urea-induced structural rearrangements in their corresponding ClpB domains. 
The remaining five single-Trp ClpB variants (W105, W462, W543, W603, and 
W812) show cooperative urea-induced transitions, which are consistent with two-state 
unfolding of the corresponding structural domains of ClpB (see Fig. 3.1). The pre-
transition increases in fluorescence intensity are found for W543 under monomeric 
conditions (Fig. 3.4E) and for W603 (Fig. 3.4F). We assume that pre-transition intensity 
increases are due to urea-induced changes in fluorescence quenching for the 
fluorophores that are partially solvent-exposed in the native structure of ClpB. 
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The urea-induced cooperative conformational transitions are often described with 
the following empirical relationship: ΔG([D]) = ΔG0 - m[D] (Pace, 1986), where ΔG0 is 
the standard free energy of unfolding of a given domain under urea-free conditions, [D] 
is molar concentration of urea, and m is an empirical constant. The above equation 
predicts that the standard free energy of protein unfolding (ΔG) decreases with an 
increasing urea concentration, which increases the equilibrium population of the 
unfolded conformation and decreases that of the native state. 
We used the above empirical relationship to describe the cooperative urea-
induced transitions in the Trp fluorescence intensity (Fig. 3.4A and D-G). The 
parameters of the equation, ΔG0 and m, are listed in Table 3.1 for five single-Trp ClpB 
variants. The D2 large domain that contains Trp603 is the most stable among the 
domains of monomeric ClpB (as shown by the values of ΔG0). The coiled-coil domain 
that contains Trp462 is the least stable. Upon oligomerization of ClpB, no significant 
changes of domain stability are found for the N-terminal domain (W105), the small D1 
domain (W543), and the large D2 domain (W603). However, the ClpB oligomerization 
significantly destabilizes the small D2 domain (W812) and, to a lower extent, the coiled-
coil domain (W462). This result indicates that the two domains may undergo significant 
structural rearrangements during formation of the ClpB ring. In the oligomeric ClpB, the 
coiled-coil and D2 small domain may lose some inter-domain contacts that contribute to 
their stability in the monomeric form. Conversely, in the oligomeric ring, these domains 
may form new contacts with partner domains of the neighboring subunit. Indeed, our 
previous studies showed that the contacts mediated by the D2 small domain are 
necessary for the stability of the ClpB ring. Removal of the D2 small domain completely 
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inhibits the formation of ClpB oligomers in the absence or in the presence of nucleotides 
(Barnett et al., 2000). Deletions within the coiled-coil domain also destabilize the 
oligomers of ClpB (Kedzierska et al., 2003). In the high-resolution structure of the T. 
thermophilus ClpB oligomer (Lee et al., 2003), both the coiled-coil domain and the D2 
small domain form the outside “layer” of the ring. The two domains form extensive 
contacts with the large D1 and D2 domains, respectively, of the neighboring subunit 
within the ring. The mechanism of stabilization of the ClpB ring by contacts maintained 
by the coiled-coil and the D2 small domain is consistent with the oligomerization-
induced changes in those domains’ stabilities that were detected in the present work.  
The remaining ClpB domains: the mobile N-terminal domain, the D2 large 
domain, and the D1 small domain, which serves as a “hinge” for the coiled-coil (see Fig. 
3.1) do not change their stability in the oligomeric ClpB (see Fig. 3.4). This result 
indicates that the core of the AAA+ module is a rigid structural unit that can be 
assembled into an oligomeric ring and “fastened” to its neighbors by contacts 
maintained by the coiled-coil and the D2 small domain. This work is the first protein 
stability study of a AAA+ ATPase. 
Nucleotide-induced conformation changes in ClpB  
The single-Trp variants produced for the stability studies were also used in 
another set of experiments, one designed to follow the nucleotide-induced 
conformational changes in ClpB. The change in the fluorescence emission spectra was 
followed after addition of saturating amounts of ADP or ATP. These experiments were 
performed under conditions which favored the formation of ClpB oligomers (low ionic 
strength buffer and 0.6 mg/ml protein concentration), thus the changes in the 
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fluorescence intensity were the consequences of local conformational changes which 
occurred after nucleotide binding to an already oligomeric ClpB variant (during the 
heptamer-hexamer switch). Several of the Trp variants of ClpB responded to nucleotide 
binding. The biggest change in the fluorescence emission intensity was observed in 
case of the channel probe (W251). In this ClpB variant, the fluorescence emission 
intensity decreased significantly after addition of saturating amounts of ADP (19.5 %) or 
ATP (17.5 %) (Fig. 3.5A). This decrease of intensity suggests that the Trp residue 
located on the mobile loop that lines the channel entrance of the ClpB oligomer, 
becomes more accessible to solvent quenching upon nucleotide binding. The middle 
domain probe (W462) showed a significant increase in the emission intensity in the 
presence of ADP (18.7 %) as well as ATP (13 %) (Fig. 3.5B). This decrease in 
quenching could signal a conformational change in the middle domain of ClpB upon 
nucleotide binding as a result of which Trp462 is buried and the emission quenching is 
decreased. Interestingly this naturally occurring Trp residue is located at the base of the 
propeller-like middle domain, and in the homology model of the E. coli ClpB, it is 
oriented towards the small D1 sub-domain. Indeed, recent data indicated that the 
middle domain contacts the first AAA+ domain of ClpB in a nucleotide dependent 
manner and could facilitate the cooperation between the different subunits of the ring 
(Haslberger et al., 2007; Lee et al., 2007). 
The most interesting result was obtained for the Trp603 probe, the one located in 
the large domain of the second AAA+ motif near the conserved Walker B motif. For this 
variant, ADP binding caused a decrease (14 %), while ATP binding caused an increase 
in the fluorescence intensity of this Trp residue (10 %) (Fig. 3.5C). This result suggests 
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a significant change in the environment of Trp603 upon the hydrolysis of ATP 
molecules, possibly a conformational change which makes this residue more accessible 
to solvent quenching. It is interesting to note, that the domain stability studies indicated 
that the same domain does not undergo a significant conformational change during 
oligomerization (stability did not changed from monomer to heptamer). So, while the 
large domain of the second AAA+ module constitutes the relatively rigid core of the 
ClpB disaggregating machine, it is still able to undergo major conformational changes 
upon ATP hydrolysis. It is believed that these and similar conformational changes which 
occur in and around the central channel of the ClpB oligomer are responsible for the 
substrate translocation activity. Finally, in the case of the fluorescence probe located in 
the D2 small C-terminal domain, ADP binding caused a small (9%) increase in the 
emission intensity, while ATP binding had no effect on the intensity of the fluorescence 
(Fig. 3.5D). However, both ADP and ATP binding caused a shift toward longer 
wavelengths in the maximum of the emission spectrum of the Trp812 (from 348 nm to 
352.5 nm and from 348 nm to 350.5 nm, respectively). This “red shift” towards longer 
wavelengths of the maximum of intensity suggests that the Trp812 becomes more 
exposed as a result of nucleotide binding (especially ADP binding) or may form different 
contacts with the rest of the protein. The domain stability studies suggested that the D2 
small domain probably also undergoes conformational change upon oligomerization.  
In case of the remaining fluorescence probes (W105, W276, W543), addition of 
saturating amounts of ADP or ATP did not result in significant change of the emission 
intensity. This is an indication that those locations do not undergo significant 
conformational changes upon ATP binding or hydrolysis. Interestingly, among these 
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probes Trp543 together with Trp105 showed the lowest quenching (highest intensity) 
among the probes and Trp276 probe showed the highest quenching (lowest intensity) 
(Fig. 3.3B). 
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Figures 
 
Figure 3.1   Location of Trp fluorescence probes in E. coli ClpB. 
(A) Positions of single-Trp probes within ClpB. (B) Monomeric structure of the E. coli 
ClpB (as determined by homology modeling and presented in Chapter 2). The N-
terminal domain (green) is on top of the figure, followed by the D1 AAA+ large (orange) 
and small domain (purple), the middle coiled-coil domain (blue), and the D2 AAA+ large 
(orange) and small (purple) domains. Positions of the aromatic residues mutated to Trp 
are shown in red spheres. The location of the entrance to-and exit from-the ClpB central 
channel is also indicated. 
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Figure 3.2   ATPase activity of wild type ClpB and its single-Trp variants. 
The rate of ATP hydrolysis catalyzed by wt ClpB or its variants, each with a single Trp at 
the indicated position, was measured at 37 °C without (A) or with 0.1 mg/ml κ-casein 
(B). Averages from three measurements are shown with the standard deviations. 
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Figure 3.3   Fluorescence emission spectra of the single-Trp variants of ClpB.  
The excitation wavelength was 300 nm and the emission spectra were measured for 
each of the variants of ClpB indicated in the figure at 0.1 mg/ml in the buffer F (50 mM 
Tris/HCl pH 7.5, 20 mM MgCl2, 1 mM EDTA, 1 mM DTT) with 0.3 M KCl (A) or at 0.5 
mg/ml in buffer F without KCl (B). 
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Figure 3.4   Urea-induced changes of fluorescence intensity in single-Trp ClpB 
variants. 
Shown are the data for monomeric ClpB (0.1 mg/ml in 50 mM Tris/HCl pH 7.5, 20 mM 
MgCl2, 1 mM EDTA, 1 mM DTT with 0.3 M KCl and indicated urea concentrations, red 
filled symbols) and oligomeric ClpB (0.5 mg/ml in 50 mM Tris/HCl pH 7.5, 20 mM MgCl2, 
1 mM EDTA, 1 mM DTT with indicated urea concentrations, green open symbols). The 
emission intensity was measured at equilibrium for the ClpB variants containing Trp at 
the following positions: W105 (A), W251 (B), W276 (C), W462 (D), W543 (E), W603 (F), 
and W812 (G). In panels A and D through G, shown are the nonlinear least-squares fits 
of the data using the two-state unfolding model (see text) for monomeric ClpB (red solid 
line) and oligomeric ClpB (green dashed line). 
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Table 3.1   Parameters of the urea-induced two-state unfolding transitions in 
single-Trp variants of ClpB. 
The standard energy of unfolding under urea-free conditions (ΔG0) and the empirical 
constant (m) is shown for the single-Trp variants (that showed cooperative urea-induced 
transitions) for the monomeric and the oligomeric condition (see text and ref.(Pace, 
1986)). 
 
 
 
 
 
 
 88
 
Figure 3.5   Nucleotide-induced changes in fluorescence intensity of single-Trp 
ClpB variants. 
Fluorescence emission spectra of the four single-Trp variants of ClpB that responded to 
the nucleotide binding: W251 (A), W462 (B), W603 (C), W812 (D). Spectra were 
measured in low-salt buffer (50 mM Tris, pH 7.5, 20 mM MgCl2, 1 mM EDTA, and 1mM 
DTT) without nucleotides (left and right panels, black solid line), with 2 mM ADP (left 
panels, red dashed line) or with 2 mM ATP (right panels, blue dotted line). The 
concentration of the ClpB variants was 0.6 mg/ ml and the excitation wavelength was 
set at 300 nm. 
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CHAPTER 4 - Development of a novel assay for studying 
ClpB interaction with strongly aggregated proteins 
 
Introduction 
Understanding the mechanism of protein disaggregation mediated by ClpB 
involves characterization of the initial step of recognition and binding of aggregated 
substrates. However, isolation of complexes of ClpB with aggregated substrates is a 
challenging task partly due to the poorly defined nature of the aggregated proteins and 
partly due to the fact that ClpB is a highly dynamic protein. While DnaK has a high 
affinity for substrates in the ADP-bound form (Mayer and Bukau, 2005), stabilization of 
ClpB interaction with substrate proteins requires the presence of ATP. In early reports, 
even as aggregated proteins were detected in complex with the DnaK system, both in 
vivo and in cell extracts, complexes between ClpB and proteins aggregates  were not 
identified (Mogk et al., 1999). This observation was attributed to the transient nature of 
the ClpB-substrate interaction, as ClpB quickly hydrolyzes the bound ATP. 
The first evidence for a direct interaction between ClpB and substrate proteins 
was obtained with the help of a ClpB variant with mutations of the conserved glutamates 
in the Walker B motifs in both AAA+ domains (E279A/E678A) (Weibezahn et al., 2003). 
This double mutant, referred to as ClpBTrap, is able to bind ATP, but is unable the 
hydrolyze it, thus “traps” ClpB in ATP-bound conformation that has high affinity for 
substrates. Although ClpBTrap is able to stabilize interaction with substrates, it 
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represents a dead-end chaperone as it is unable to perform work on the bound 
substrates. An analogous double Walker B mutant was also produced previously in our 
laboratory (E279Q/E678Q) and it was successfully used to detect the ATP-dependent 
interaction of ClpB with aggregated substrates using gel filtration (GF) chromatography 
(Barnett et al., 2005). The interaction of ClpBTrap with aggregated proteins is detected 
in presence of ATP by co-elution of ClpB with the large aggregates. Although GF 
chromatography is a straightforward and undoubtedly useful approach for the study of 
ClpB-aggregate interaction, it has several limitations. The borderline solubility of the 
strongly aggregated proteins, the long separation time, and large dilution of the proteins 
on the column are the most obvious drawbacks. The goal of this project was to develop 
a new assay that can be used quickly and efficiently to detect interaction between large 
aggregates and ClpB.  
Characteristics of the aggregated substrates 
Enzymes are often used as aggregated substrates for chaperones since their 
refolding/ reactivation can be easily followed by the regaining of their enzymatic activity. 
Previously, we developed a modified version of the procedure used by Goloubinoff and 
coworkers (Diamant et al., 2000) for the production of aggregated glucose-6-phosphate 
dehydrogenase (G6PDH) (Barnett et al., 2005). G6PDH aggregates can be produced 
by first unfolding the native G6PDH in 5 M urea at 47˚C followed by rapid dilution into a 
refolding buffer and further incubation at 47˚C. The size of the aggregates can be 
controlled by the initial concentration of G6PDH and the incubation time in the refolding 
buffer. The aggregation process can be arrested by a rapid cooling of the samples and 
the resulting aggregates remain stable for several hours. It has been shown that DnaK 
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system alone can reactivate small aggregates, but as the size of the aggregates 
increases the reactivation process requires the chaperone activity of ClpB (Diamant et 
al., 2000). Thus the aggregates used as substrates for the ClpB-DnaK bichaperone 
system are often very large and have borderline solubility.  
Indeed, GF chromatography confirmed that large G6PDH aggregates elute at the 
void volume fraction of a Superose 6 column corresponding to a molecular weight larger 
than 2,000 kDa (Barnett et al., 2005).  Imaging with TEM showed that the aggregated 
G6PDH has a globular shape with an average diameter of approximately 50 nm (results 
not shown). The aggregation process is very sensitive to the initial concentration of the 
protein and the environmental conditions. Thus, there is a fine line between producing 
soluble non-turbid aggregates or turbid aggregates with low solubility. The HPLC 
system and the GF column can be seriously damaged by large particulate aggregates, 
thus extra care must be taken to produce aggregates that are large but still applicable to 
the HPLC system.  
 Filter assay procedure 
The new filter assay is based on the large difference between the size of the 
hexameric ClpB and aggregated proteins. It is designed especially to detect interaction 
of ClpB with large, even turbid, aggregated substrates. With this newly developed filter 
assay, the separation of the aggregate-bound fraction of ClpB from the free ClpB is 
achieved simply by using centrifugal filter devices. We chose filter units with Durapore 
membrane (it has the lowest protein binding capacity among the microporous 
membranes) with 0.1 μm pore size. These units have a maximum capacity 0.5 ml and a 
hold-up volume of only 5 μl (Amicon-Ultrafree MC, Millipore). 
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To study ClpB binding to aggregated substrates, the aggregated proteins were 
mixed with a solution containing ClpB and excess of nucleotides, than incubated for a 
short time while shaking at a slow speed. A small aliquot of the aggregate-ClpB mixture 
was applied to the filter unit and centrifuged. Small proteins passed through, while large 
aggregates were retained by the filter. An additional washing step with a buffer 
containing the appropriate nucleotide was included to decrease the amount of 
nonspecifically or weakly bound proteins. Proteins retained on the membrane were 
eluted with SDS buffer after short incubation at high temperature. The resulting filtrates 
(small proteins not retained by the filter) and eluates (fractions eluted from the filter with 
SDS buffer) were analyzed by SDS-PAGE followed by Coomassie blue staining (see 
flowchart below, Fig. 4.1). 
Results and Discussion 
An example of a filter assay used for the detection of ClpB bound to aggregated 
G6PDH is illustrated in Fig. 4.2.  Native G6PDH as well as the majority of ClpB are 
found in the filtrate fraction (left panel), while aggregated G6PDH was retained on the 
filter and found in the eluant fraction (right panel). Trace amounts of ClpB were also 
retained on the filter in control samples of native G6PDH, as well as in aggregate 
containing samples in absence of nucleotides or with ADP and ATP.  The interaction 
between wild type ClpB and G6PDH aggregates was detected only in presence of the 
poorly-hydrolyzable ATP analog, as significant amounts of ClpB were found in the 
aggregate fraction only in presence of ATPγS.  This is in agreement with the previously 
observed nucleotide-dependence of the ClpB-aggregate interaction (Diamant et al., 
2000; Barnett et al., 2005), namely with the observation that the ClpB-aggregated 
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substrate interaction is stabilized in the presence of ATP when the ClpBTrap variant is 
used. Similarly, our results show that binding of the poorly-hydrolysable ATPγS to wild 
type ClpB reproduces the frozen ATP-bound conformation of ClpBTrap, and thus 
stimulates the interaction of ClpB with the aggregated G6PDH.  In the next chapter, 
examples will be provided for detection of the interaction of ClpBTrap with the 
aggregated substrates in the presence of ATP and the DnaK cochaperone system.  
Additionally, the filter assay was successfully used to detect binding-deficiencies 
of a ClpB double Walker A mutant protein ClpB (T213N/T612N). For this experiment a 
second enzyme was also used as aggregated substrate for ClpB. Similar to G6PDH 
aggregates, it has been also shown that malate dehydrogenase (MDH) can be 
reactivated by the combined action of ClpB and the DnaK chaperone system 
(Goloubinoff et al., 1999). The filter assay was performed as described above and the 
fractions retained on the filter and subsequently solubilized with an SDS buffer (eluates) 
were analyzed by SDS-PAGE (Fig. 4.3). The control samples in lanes 1-4 confirm that 
the native G6PDH (Fig. 4.3A) or MDH (Fig. 4.3B) is not retained on the filter, while both 
aggregated G6PDH and aggregated MDH are retained on the filter (lanes 5-12). Only 
background amounts of wt ClpB and ClpB (T213N/T612N) were retained on filters in the 
absence of aggregates without nucleotides (lanes 1-2) or in presence of ATPγS (lanes 
3-4),  as well as in presence of aggregates in nucleotide free condition (lanes 5-6) or in 
presence of ATP (lanes 7-8) or ADP (lanes 11-12). As expected, binding of wt ClpB to 
G6PDH aggregates or to MDH aggregates was stimulated by ATPγS (lane 9). However, 
these experiments revealed the aggregate-binding deficiencies of  ClpB 
(T213N/T612N),  as even in presence of ATPγS,  the double Walker A mutant showed 
 96
only background binding to aggregated G6PDH (lane 10, panel A) or aggregated MDH 
(lane10, panel B).  
As shown above, the filter assay is a simple procedure that can be used to study 
the interaction between ClpB, or different mutated variants of ClpB, with aggregated 
substrates. This assay has several advantages over the previous assay used for the 
detection of ClpB-aggregates interaction.  
Detection of ClpB-aggregate interaction with GF chromatography requires ten 
times more concentrated solutions of ClpB and aggregates, larger volumes and longer 
running times for each experiment. When more than one condition has to be checked 
(like binding in presence of different nucleotides) a separate run has to be performed for 
each condition and the GF column has to be equilibrated accordingly between the 
different runs. Extra care has to be taken to prevent accumulation of aggregated 
proteins that can damage the GF column and the HPLC system. In addition, fresh 
sample of aggregated protein has to be prepared immediately prior to each run. Also, in 
order to detect wt ClpB interaction with aggregates in the presence of ATP, the 
collected fractions have to be concentrated approximately 20 times to allow detection 
with SDS-PAGE.  For the most part the ClpBTrap version has to be used to stabilize the 
interaction in the presence of ATP (Barnett et al., 2005). Due to the high cost of ATPγS, 
equilibration of the columns and running of a large number of experiments can become 
a major hassle.  
In contrast the filter assay does not require highly concentrated solutions, works 
well with small volumes and large, even turbid aggregates. In addition, the separation of 
the aggregate-bound and free ClpB is a very quick process and allows for the 
 97
simultaneous processing of a large number of samples. Moreover, the same 
preparation of aggregated proteins can be divided between the different samples, which 
in turn makes the comparison among various samples and conditions more reliable. 
Due to the small volume required for the assay, ATPγS can be successfully used to 
stabilize the ClpB-aggregate interaction and the production of the ClpBTrap version is 
not required. This is especially important when several other ClpB mutants have to be 
screened, and the introduction of two more mutations is a time consuming process.  
Most importantly, this simple assay could reproduce the previously published 
results regarding ClpB-aggregate interaction (Fig. 4.2) and additionally it has been used 
to characterize aggregate-binding capabilities of new ClpB mutants (Fig. 4.3). The 
disadvantage of the filter assay is that it can be only used to detect ClpB binding to 
large aggregates (like the examples presented above) and it is not possible to follow the 
ClpB-aggregate interaction in an aggregate-size dependent manner. For this purpose 
the GF chromatography-based method still remains the experiment of choice. 
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Figures 
Figure 4.1   Filter Assay Flow Chart. 
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Figure 4.2   ClpB binds to aggregated G6PDH in presence of ATPγS. 
1.5 μM ClpB was incubated with 2.7 μM native (N) or aggregated G6PDH without 
nucleotides or in the presence of 5 mM ATP, ATPγS or ADP, as indicated. 75 μl aliquots 
were applied to filter units and filtrates and eluates were separated by centrifugation. 
The results of the SDS-PAGE are shown with the filtrate and eluate fractions on the left 
and right side of the figure, respectively.  
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Figure 4.3   Interaction of ClpB and ClpB (T213N/T612N) with aggregated 
substrates. 
1.5 μM wt ClpB, or ClpB(T213N/T612N) were incubated with 2.7 μM  native or 
aggregated G6PDH (A) or 3  μM native or aggregated MDH (B) without nucleotides or 
with 5 mM ATP, ATPγS, or ADP. The result of SDS-PAGE is shown only for the 
fractions retained on the filter and subsequently solubilized with an SDS buffer 
(eluates). Lanes 1-4 are the control lanes with native proteins, while lanes 5-12 contain 
aggregated substrates. 
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CHAPTER 5 - Studies on functionality of the ClpB95/ClpB80 
hetero-oligomers 
 
Introduction 
The ClpB transcript contains an alternative translation initiation site at the N-
terminus of the first AAA+ module. Consequently, two isoforms of ClpB are produced in 
vivo: the full-length 95-kDa ClpB (ClpB95) and a truncated 80-kDa ClpB (ClpB80) that 
lacks the whole N-terminal domain of the full-length ClpB (Fig. 5.1) (Woo et al., 1992). 
Both isoforms of ClpB are localized in the bacterial cytoplasm and the truncated ClpB80 
accounts approximately for one third of the total amount of ClpB (Chow and Baneyx, 
2005).  
Within the family of AAA+ ATPases, production of different-size isoforms is not 
restricted to ClpB. Truncated isoforms arising from alternative translation initiation sites 
were found for the close bacterial Clp ATPase ClpA, (Seol et al., 1994) and for spastin, 
a mammalian AAA+ ATPase involved in microtubule severing (Claudiani et al., 2005). 
The alternative N-termini in isoforms of AAA+ ATPases are located between the AAA+ 
modules and the “attachment” domains, which suggests that such domains may be 
functionally dispensable. The reasons for production of multiple isoforms of AAA+ 
ATPases are, however, poorly understood.  
It is relevant to investigate the biological significance of production of two ClpB 
isoforms and the role of the truncated ClpB isoform in the ClpB-mediated 
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disaggregation process, especially in the light of the controversy surrounding the role of 
the N-terminal domain of ClpB (as described in Chapter 1). 
Recent published data indicated that the optimal survival of E. coli during heat-
shock is achieved when both ClpB95 and ClpB80 are produced in vivo (Chow and 
Baneyx, 2005). This result suggests that the two isoforms of ClpB may cooperate in 
producing a highly efficient chaperone system. 
Materials and Methods 
Proteins 
ClpB95, ClpB80, and their double-Walker B mutant variants ClpB95Trap and 
ClpB80Trap, as well as the glycine insertion variant GI144ClpB were produced as 
described in Chapter 3. Previously published procedures were used to purify DnaK 
(Zmijewski et al., 2004), and DnaJ (Zylicz et al., 1985). GrpE was obtained from 
StressGen Biotechnologies (Victoria, Canada). Glucose-6-phosphate dehydrogenase 
(G6PDH) from Leuconostoc mesenteroides was obtained from Sigma (St. Louis, 
Missouri) in a lyophilized form. Porcine heart mitochondrial malate dehydrogenase 
(MDH) used in the reactivation assays and in the filter assays were obtained from MP 
Biomedicals (Irvine, California) and from Roche Pharmaceuticals, respectively. Protein 
concentrations were determined spectrophotometrically and are given in monomer 
units. 
Production of protein aggregates  
To prepare aggregated G6PDH, 440 µM stock solution of G6PDH was diluted 
two times with the heated denaturation buffer (10 M urea, 16 % glycerol, and 40 mM 
DTT). The mixture was incubated at 47 °C for 5 min, after which the G6PDH sample 
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was quickly diluted ten times with buffer A (50 mM triethanolamine/Cl, pH 7.5, 20 mM 
Mg(OAc)2, 30 mM KCl, 1 mM β-mercaptoethanol, and 1 mM EDTA) and was mixed 
vigorously and incubated at 47 °C for 1 min or 15 min. The solution was then mixed 
briefly and incubated further on ice for 2 min followed by centrifugation at 4 °C for 10 
min at 13,000 g. The samples prepared for the HPLC runs contained an additional 2 
mM ATP in buffer A.  
To prepare aggregated MDH for the reactivation assays, 250 µM stock solution 
was diluted 20-fold in buffer B (100 mM Tris pH 7.4, 120 mM KCl, 15 mM Mg(OAc)2, 8 
mM DTT) and incubated at 47 °C for 60 min. The solution was then mixed and 
incubated on ice for 2 min. MDH aggregates for the filter assays were prepared the 
same way as aggregated G6PDH. 
Protein reactivation assay  
Aggregates of G6PDH (22 µM) were diluted 8-fold in buffer A with 6 mM ATP 
containing either no chaperones, 1 µM DnaK, 1 µM DnaJ and 0.5 µM GrpE (KJE) with 
1.5 µM ClpB95, KJE with 1.5 µM ClpB80, or KJE with the mixtures of ClpB95 and 
ClpB80 (total 1.5 µM ClpB). Aggregates of MDH (12.5 µM) were diluted to 3 µM in 
buffer B with 6 mM ATP containing either no chaperones, KJE with 1.5 µM ClpB95, KJE 
with 1.5 µM ClpB80, or KJE with the mixtures of ClpB95 and ClpB80 (total 1.5 µM 
ClpB). After incubation at 30 °C, aliquots were withdrawn and the G6PDH or MDH 
activity was measured. 
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G6PDH and MDH activity assay  
G6PDH samples were incubated at 30 °C in 50 mM Tris-HCl pH 7.8, 5 mM 
MgCl2 with 2 mM glucose-6-phosphate and 1 mM  NADP+. The absorption at 340 nm 
was measured after 5 min. 
MDH samples were incubated at 25 °C in 50 mM Tris-HCl pH 7.4, 2 mM DTT, 
0.3 mM oxaloacetate, and 0.15 mM NADH. The absorption at 340 nm was measured 
after 20 min. 
Analytical ultracentrifugation 
A Beckman Optima XL-I analytical ultracentrifuge was used in sedimentation 
studies. Sedimentation velocity experiments were performed at 50,000 rpm at 20 °C 
using two-channel aluminum analytical cells. ClpB solutions were prepared in 50 mM 
Tris-HCl pH 7.5, 0.2 M KCl, 20 mM MgCl2 1mM EDTA and 2 mM β-mercaptoethanol. 
The data were analyzed using the time-derivative method (Stafford, III, 1992) and 
software distributed with the instrument. 
Gel filtration chromatography  
Protein samples were injected onto a 25-cm Pharmacia HR10/30 column packed 
with Superose 6 gel filtration media (Amersham Biosciences) equilibrated with buffer A 
with 2 mM ATP. Elution at 0.5 ml/min was performed at room temperature using a 
Shimadzu HPLC LC10ATvp equipped with a SPD-M10Avp diode-array detector. One-
minute fractions (0.5 ml) were collected from the column and analyzed by SDS-PAGE 
followed by Coomassie staining. Band densitometry was performed using Scion Image 
software (www.scioncorp.com). 
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ClpB ATPase assay  
ClpB samples were incubated for 15 min at 37 °C in 100 mM Tris-HCl pH 8, 10 
mM MgCl2, 5 mM ATP, 1 mM EDTA, 1 mM DTT with 0.2 mg/ml α-casein (Sigma) or 5 
μM peptide B1. Inorganic phosphate production was determined using the malachite 
green method (Hess and Derr, 1975; Lanzetta et al., 1979). 
Peptide B1 (AHAWQHQGKTLFISRKTYRIC) was synthesized at KSU Biotech 
Core Facility and further purified on reverse phase-HPLC (RP-HPLC).  
Normal mode analysis  
The PDB coordinates of the iMolTalk hexameric model of full-length 
T.thermophilus ClpB were downloaded from http://i.moltalk.org/ . The ElNemo web 
server (http://www.igs.cnrs-mrs.fr/elnemo/) was used to compute a b-factor or 
temperature factor for each residue based on the first 100 normal modes that 
characterizes the mobility of the residues. One set of calculations was performed on the 
hexamer composed of six full-length chains, while in the second case, the hexamer was 
composed of three long chains (A, C, E) and three short ones (B, D, F) with the N-
terminal domain (residues 4-139) removed.  
Results 
 Chaperone activity of ClpB80 and ClpB95 
Research regarding the role of the N-terminal domain of ClpB was initiated by 
former members of our lab. It has been shown that the N-terminal domain of ClpB95, 
which is missing in ClpB80, contributes significantly to the aggregate-binding affinity. 
Most importantly, the N-terminal domain becomes essential for binding large protein 
aggregates of G6PDH (Barnett et al., 2005).   
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In order to compare the chaperone activity of the two isoforms we followed the 
reactivation of G6PDH in presence of ClpB and the DnaK/DnaJ/GrpE system of 
cochaperones as a function of the size of the aggregates. Small or large aggregates of 
G6PDH were produced (as described in Chapter 4) by arresting the aggregation 
process after 1min or 15 min refolding time, respectively. Gel filtration chromatography 
confirmed that aggregates produced after 1 min of refolding time, showed a broad 
distribution of particles with a maximum at ~1,000 kDa, while the aggregates produced 
after 15 min of refolding time eluted in the void-volume fraction corresponding to 
>~2,000 kDa with a minor fraction of smaller aggregates (Fig.1 from ref. (Barnett et al., 
2005)). 
We compared the rates of G6PDH reactivation by different chaperones for the 
aggregate population prepared with 1 min and 15 min refolding time. As shown in Fig. 
5.2A (open circles), the 1-min aggregate population showed measurable G6PDH 
activity that did not increase over time, which indicates that the aggregate population 
contains a fraction of refolded native G6PDH. The fact that the amount of refolded 
G6PDH did not increase spontaneously over time is consistent with the irreversible 
nature of protein aggregation. Either DnaK/DnaJ/GrpE (KJE) alone or in cooperation 
with ClpB reactivated aggregated G6PDH, but the reactivation rate was ~4-fold higher 
when ClpB95 was present. The rate of G6PDH reactivation was ~2-fold lower when the 
full-length ClpB was replaced with ClpB80. 
In contrast to the 1-min aggregate sample, the 15-min aggregate population had 
no measurable G6PDH activity (Fig. 5.2B, open circles), which indicates that essentially 
all G6PDH aggregated during 15 min of refolding. The DnaK/DnaJ/GrpE system alone 
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did not reactivate G6PDH, which is consistent with previous observations (Diamant et 
al., 2000).  
Either ClpB95 or ClpB80 reactivated G6PDH, but the reactivation rate was in this 
case ~5-fold lower with ClpB80 than with the full-length ClpB. Collectively, the results in 
Fig. 5.2 indicate that the chaperone activity of ClpB80 is weaker than that of ClpB95. 
The ability of ClpB80 to reactivate aggregated G6PDH decreases as the size of the 
aggregates increases (comp. Figs. 5.2A and 5.2B). This result is consistent with the 
weaker binding of ClpB80 to the large aggregates of G6PDH. The fact that ClpB80 is 
less efficient than ClpB95 in reactivation of strongly aggregated G6PDH questions the 
role of ClpB80 isoform in the cellular protein disaggregation. Also, if the truncated 
version is less efficient then why has the alternative translation initiation site in the ClpB 
gene not been eliminated during evolution? 
Combined chaperone activity of ClpB80 and ClpB95   
Since DnaK system alone could not reactivate the large aggregates of G6PDH 
(produced with 15 min refolding time), and also the requirement for the N-terminal 
domain of ClpB95 was essential for the reactivation of the aggregates, we used large 
aggregates of G6PDH to follow the combined chaperone activity of ClpB95 and ClpB80. 
The reactivation assays were performed in the presence of the DnaK system and 
different molar fractions of ClpB80 (fClpB80) while keeping the total concentration of ClpB 
constant among the various samples.  
Since ClpB80 was unable to reactivate efficiently the G6PDH aggreagates, it was 
expected that the “dilution” of the active ClpB95 chaperone with ClpB80 would lower the 
chaperone activity of the mixture as compared to the same concentration of ClpB95. 
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Unexpectedly, we observed a strong activation of the chaperone activity (over 100% 
increase in the G6PDH reactivation rate) when both ClpB95 and ClpB80 were used in 
the reactivation assay (Fig. 5.3). The highest chaperone activity was observed for 1:1 
molar ratio of ClpB80 and ClpB95 (fClpB80 = 0.5) (Fig. 5.3, inset). We wanted to see if this 
enhancement of chaperone activity, observed in presence of the mixtures of ClpB80 
and ClpB95, is specific to the aggregates of G6PDH, or it is a more general property of 
ClpB. Consequently, we followed the reactivation rates of thermally-aggregated MDH, 
whose reactivation does not appear to depend on the presence of the N-terminal 
domain of ClpB to the extent observed for aggregated G6PDH (Mogk et al., 2003). 
Indeed, these reactivation assays showed that, in contrast to the result obtained in case 
of G6PDH aggregates, the MDH aggregates were reactivated with similar rate by 
ClpB80 or ClpB95 in the presence of the DnaK system (note the lack of difference 
between the traces for fClpB80 = 0 and fClpB80 = 1) (Fig. 5.4). But most importantly, just like 
in case of the G6PDH, the reactivation rate of aggregated MDH significantly increased 
in the presence of both ClpB95 and ClpB80 with the maximum at 1:1 molar ratio of the 
ClpB isoforms (Fig. 5.4, inset). These results demonstrate that the mixtures of ClpB95 
and ClpB80 work more efficiently as aggregate reactivating chaperones than either 
ClpB95 or ClpB80 alone. 
Self-association of ClpB80 and ClpB95 
The synergistic activation of the ClpB chaperone system by a concerted action of 
ClpB95 and ClpB80 might be linked to the formation of hetero-oligomers containing both 
ClpB isoforms. Indeed, Kim et al. detected interactions between ClpB80 and His-tagged 
ClpB95 on a nickel column in presence of ATP (Kim et al., 2000). It has been shown by 
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our lab previously that the self-association affinity of ClpB80 is higher than that of 
ClpB95, which correlates with a higher basal ATPase activity of ClpB80 (Barnett et al., 
2000) (see also Fig. 5.10, below). We asked, whether ClpB80 could stimulate 
oligomerization of ClpB under conditions that do not favor the oligomerization of 
ClpB95, i.e. at low protein concentration and in the absence of nucleotides. 
Sedimentation velocity experiments showed that 5 µM ClpB95 was monomeric in the 
absence of nucleotides (sedimentation coefficient s20,w ~ 4 S), as also was 2.5 µM 
ClpB80 (Fig. 5.5A). However, when 5 µM ClpB95 was combined with 2.5 µM ClpB80, a 
significant population of oligomers (s20,w ~ 13 S) was observed (Fig. 5.5B). Since neither 
of the two isoforms formed homo-oligomers at such protein concentration, the oligomers 
found in Fig. 5.5B represent hetero-oligomers of ClpB95 and ClpB80. This result 
indicates that the formation of hetero-oligomers is preferred over the formation of homo-
oligomers at low concentration of ClpB95 and ClpB80. 
In the experiment shown in Fig. 5.5B, the total ClpB concentration was 7.5 µM. 
ClpB95 at similar concentration remained monomeric (Fig. 5.5C), but ClpB80 formed 
homo-oligomers with the sedimentation coefficient similar to that of the hetero-oligomers 
shown in Fig. 5.5B. This result indicates, first, that the self-association affinity of ClpB80 
is indeed higher than that of ClpB95 and, second, that the size of the hetero-oligomers 
is similar to that of ClpB80 homo-oligomers (i.e. hexameric). Since the difference in 
molecular weight between ClpB95 and ClpB80 is only ~15%, the resolution of 
sedimentation studies is not sufficient to determine the exact composition of hetero-
oligomers, nor it is possible to determine whether their population is homo-or 
heterogeneous. 
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Binding of the ClpB hetero-oligomers to aggregated substrates 
Sedimentation velocity confirmed that the two isoforms can form hetero-
oligomers. In an attempt to explain the enhanced chaperone activity of the hetero or 
mixed-oligomers, we investigated interactions of the aggregates with substrate-trapping 
variants of ClpB95 and ClpB80 (Weibezahn et al., 2003). As described in Chapter 4 of 
this work, interaction between ClpBTrap (E279Q/E678Q) and protein aggregates can be 
detected by gel filtration chromatography in presence of ATP (Barnett et al., 2005). 
Large aggregates of G6PDH eluted from the gel filtration column equilibrated with ATP 
at 11-13 min (see Fig. 5.6 and ref. (Barnett et al., 2005)). ClpB95Trap and ClpB80Trap 
formed hexamers in the presence of ATP and eluted at 21-23 min. In the presence of 
aggregated G6PDH, a significant fraction of ClpB95, but only a trace amount of ClpB80, 
eluted at 11-13 min (Fig. 5.6AB)  This result indicates that the N-terminal domain of 
ClpB, which is missing in ClpB80, is essential for binding to the aggregates, consistent 
with our previous results (Barnett et al., 2005). When ClpB95 and ClpB80 (1:1 molar 
ratio) were incubated with aggregated G6PDH, both isoforms of ClpB were found in the 
aggregate containing fractions (Fig.5.6C). We performed band densitometry of the 
aggregate-containing gel filtration fractions eluting at 11, 12, and 13 min (Fig. 5.6D). We 
found that the total amount of ClpB (ClpB95+ClpB80) bound to the aggregates in Fig. 
5.6C was not higher than the amount of ClpB95 bound to the aggregates in Fig. 5.6A. 
The ratio of ClpB80/ClpB95 was 0.40 ± 0.07 in the three aggregate fractions (see Fig. 
5.6D, filled circles), which suggested that the hetero-hexamers of the Walker B mutant 
ClpB that formed in the presence of ATP and bound to G6PDH aggregates contained 
an average number of 2 ClpB80 and 4 ClpB95 subunits. 
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Binding of ClpB95Trap and ClpB80Trap to aggregated G6PDH was also 
investigated with the filter assay. Aggregates were incubated with the chaperones in 
presence of ATP prior to filtration and the fractions retained on the filters were analyzed 
by SDS-PAGE (as described in Chapter 4). The results obtained in Fig. 5.7A are 
consistent with the results of the gel filtration, and confirm that the hetero-oligomers do 
not possess a higher affinity for aggregated G6PDH as compared to the homo-
oligomers of ClpB95 (compare lane 3 and lane 7, Fig. 5.7A). The weaker binding of 
ClpB80 to G6PDH aggregates was also observed with this assay. Also in case of 
aggregated MDH the total amount of ClpB (ClpB95+ClpB80) bound to the MDH 
aggregates (lane 7, Fig. 5.7B) is not higher than the amount of ClpB95 (lane 3, Fig. 
5.7B). The N-terminally truncated isoform interacted stronger with the aggregates of 
MDH than with the G6PDH aggregates (lane 5, Fig. 5.7 AB). Indeed, during the 
reactivation of MDH aggregates, ClpB80 was just as effective as ClpB95 (Fig. 5.4). 
ClpB cooperation with the DnaK system 
In addition to ClpB, the G6PDH and MDH reactivation assays contained also the 
DnaK/DnaJ/GrpE system of cochaperones. Existing data indicate an essential role of 
the DnaK system during the early steps of the disaggregation process, before the 
substrates are threaded through the central channel of the ClpB oligomers (Weibezahn 
et al., 2005; Zietkiewicz et al., 2006). Thus, the DnaK system could influence the ClpB-
aggregate interaction.  When DnaK/DnaJ/GrpE was included in the binding assays, we 
did not detect with the filter assay an increase in the amount of ClpB95, ClpB80 or the 
total amount of ClpB (ClpB95+ClpB80) bound to the aggregated G6PDH or aggregated 
MDH (lanes 4, 6, and 8, compared to lanes 3, 5, and 7, respectively, Fig. 5.7 A and B). 
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Instead, we could detect a slight decrease in the aggregate-bound ClpB that was clearly 
visible in case of ClpB95 (lane 3 compared to lane 4, Fig. 5.7A and B). This suggests 
that ClpB and DnaK compete for the same binding sites on the aggregates. Thus, the 
hetero-oligomers do not bind more aggregated G6PDH or aggregated MDH than the 
homo-oligomers of ClpB95, not even in the presence of the DnaK system. 
It has been shown that preincubation of certain protein aggregates (GFP and 
luciferase) with DnaK/DnaJ results in a faster initiation of the disaggregation and 
subsequent reactivation by the ClpB-DnaK system of cochaperones (Zietkiewicz et al., 
2004). Recently the same group proposed that large aggregates are fragmentated into 
smaller ones upon preincubation with DnaK (Zietkiewicz et al., 2006). 
We tested the role of the DnaK system on the aggregate-binding affinity of ClpB 
and on the protein reactivation mediated by ClpB in order-of-addition experiments. To 
compare binding affinities, G6PDH aggregates were preincubated 10 minutes either 
with the DnaK/DnaJ/GrpE or with ClpB95Trap in presence of ATP, after which the 
missing chaperone was added and the mixture was incubated for another 10 minutes. 
No change in the amount of ClpB95 bound to the aggregated G6PDH was observed 
between the samples that were preincubated with DnaK and the samples that were 
preincubated with ClpB (lane 13 and 14, Fig. 5.8). Also, just like before (Fig. 5.7A) 
slightly more ClpB was found in the aggregate fraction in absence of DnaK system 
(lanes 9, 10 versus lanes 11, 12; Fig. 5.8) and this amount was similar to the amount of 
ClpB associated with aggregates in the preincubated samples (lanes 9, 10 and lanes 
13, 14; Fig. 5.8). Overall the preincubation with DnaK does not seem to increase the 
amount of ClpB bound to the large aggregates of G6PDH. However, the reactivation of 
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G6PDH was affected by the preincubation with the DnaK system as compared to the 
preincubation with ClpB (Fig. 5.9). G6PDH reactivation was more efficient when the 
samples were preincubated with the DnaK system prior addition of ClpB95. This is in 
agreement with the proposed function of the DnaK upstream from the ClpB-
translocation, as it could “prepare” the aggregates prior threading through the ClpB 
channel. 
ATPase activity of the ClpB hetero-oligomers 
Next, we investigated the ATPase activity of ClpB as a function of the ClpB80 
fraction. In addition to the basal ATPase activity, the ATP hydrolysis was also measured 
in presence of pseudo-substrates that are known activators of the ClpB ATPase: α-
casein and a positively-charged peptide, “peptide B1” (AHAWQHQGKTLFISRKTYRIC) 
that has been shown to interact with ClpB (Schlieker et al., 2004). In agreement with 
previous observations, the basal ATPase activity of ClpB80 was higher, while the 
casein-activated ATPase was lower, than that of ClpB95 (Fig. 5.10.A and C) (Barnett et 
al., 2000). However, the ATPase of ClpB80 was higher than that of the ClpB95 in 
presence of peptide B1 (Fig. 5.10 A). Additionally, we found that the basal ATPase 
activity of mixtures ClpB95/ClpB80 (Fig. 5.10A), as well as the activated ATPase in the 
presence of α-casein or peptide B1 (Fig. 5.10B, C) was approximately proportional to 
the ClpB80 fraction. Thus, unlike their chaperone activity (see insets in Fig. 5.3 and 
5.4), the ATPase of ClpB95/ClpB80 mixtures did not show any “excess” activation 
above the capabilities of both isolated components. It has been shown previously that 
α-casein and positively-charged peptides bind to ClpB and are translocated through the 
channel in the ClpB hexamer even in the absence of the cochaperones (Weibezahn et 
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al., 2004). We assume, therefore, that substrate threading occurred under the 
conditions of experiments shown in Figs. 5.10B and C. Importantly, the rate of ATP 
hydrolysis by AAA+ “polypeptide-threading machines” is linked to the speed of substrate 
translocation (Kenniston et al., 2003). Thus, taking into account the results of Figs. 
5.10B and C, we conclude that the enhanced chaperone activity of hetero-hexamers of 
ClpB95 with ClpB80 is not associated with an enhanced rate of substrate threading 
through the ClpB channel. 
We also attempted to measure the ATP consumption during the time-course of 
the reactivation of aggregated G6PDH by ClpB95/ClpB80 in presence of the DnaK 
system under conditions of Fig. 5.3. Just like in case of basal and pseudo-substrate 
stimulated ATPase activity, we did not detect an enhanced ATPase in case of the 
hetero-hexamers as compared to homo-oligomers (Fig 5.10D) during the actual 
disaggregation process. However, it has to be mentioned that under the conditions of 
the reactivation assay, ClpB is not saturated by the aggregates, and also we are 
measuring the combined ATPase of ClpB and DnaK. 
 Normal mode analysis  
The results of the sedimentation velocity experiments shown in Fig. 5.5 imply that 
the formation of a full ring of the N-terminal domains in hexameric ClpB is 
thermodynamically unfavorable, as compared to rings without some or all N-terminal 
domains. The “penalty” for forming a ring of the N-terminal domains may be due to an 
unfavorable enthalpy (steric repulsion) and/or unfavorable entropy (restriction of 
mobility). Indeed, a high mobility of the N-terminal domain in a non-physiological 
incomplete ClpB oligomer has been shown by the crystal structure as illustrated in Fig. 
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2.3 (Chapter 2) (Lee et al., 2003). We used a structural model of the hexameric ClpB 
from T. thermophilus (referred to as the “iMolTalk” hexameric model in Chapter 2) 
(Diemand and Lupas, 2006) to compute and compare the mobility of the N-terminal 
domain in a homo-hexamer of ClpB95 and in a hetero-hexamer with alternating ClpB95 
and ClpB80 subunits. Fig. 5.11 shows the results of the elastic normal mode analysis 
(Suhre and Sanejouand, 2004) of oscillatory motions in ClpB hexamers. In the homo-
hexamer of ClpB95 (Fig. 5.11A, C), the normal mode analysis detects high mobility of 
two domains located at the outside of the ClpB ring: the tip of the coiled-coil middle 
domain and the C-terminal small sub-domain of D2 AAA+ module.  
The crystal structure of the non-physiological ClpB trimer also revealed that both 
domains are mobile, and among them the middle domain was found to possess the 
higher mobility. Also, earlier studies indicated that the mobility of the middle domain 
supports chaperone activity and cooperation with the DnaK system (Lee et al., 2003; 
Haslberger et al., 2007). It has been shown also that the D2 small sub-domain 
maintains the stability of the ring (Barnett et al., 2000). Domain stability studies (Chapter 
3) (Nagy et al., 2006) revealed that only the middle domains and the D2 small sub-
domains are destabilized upon oligomerization. These earlier observations validate the 
results of the normal mode analysis. Aditionally, the AAA+ modules showed no mobility 
as it was expected from domains that form the core of the ring-like hexamers of ClpB.  
However, in the ClpB95/ClpB80 hetero-hexamer, a third mobile structural region 
was detected by normal mode analysis, which corresponds to the N-terminal domain 
(Fig. 5.11B, C). The mobility of the N-terminal domain was suppressed in the ClpB95 
homo-hexamer as compared to the hetero-hexamer. This result indicates that the 
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excess thermodynamic stability of the ClpB hexamers with an incomplete N-terminal 
ring may arise from elimination of the entropic penalty due to restriction of mobility of the 
N-terminal domains. It was also apparent that the mobility of the small D2 sub-domain is 
increased slightly in the hetero-hexamers compared to the mobility in the homo-
hexamers (Fig. 5.11C). 
ClpB variant with a modified N-domain linker region 
The crystal structure of the T. thermophilus ClpB revealed that the highly mobile 
N-terminal domain is connected to the first AAA+ module via a 14-residue long flexible 
linker (residues 145-158 in E. coli ClpB, Fig. 5.12A). At the beginning of this linker 
region we identified two Gly residues followed shortly by a Ser (-GGES-). Due to their 
flexibility, glycine residues are often found in linker regions, but alanines and serines are 
also common. In order to gain additional insights about the importance of the N-domain 
mobility in ClpB-mediated protein disaggregation we produced a variant of ClpB with a 
modified N-domain linker region. We proposed to modify the length, and possibly the 
flexibility of the ClpB N-domain linker region by introducing four additional glycines 
adjacent to the existing glycines (Fig. 5.12B). The resulting ClpB variant, GI144ClpB 
(glycine insertion after residue # 144), was tested for structural and functional integrity. 
Sedimentation velocity studies confirmed that the self-association ability of ClpB was 
not disrupted by the Gly insertions, since GI144ClpB formed oligomers at high protein 
concentration similar to ClpB95 (results not shown). Moreover, the glycine insertion 
mutant was able to hydrolyze ATP at the same rate as ClpB95 (0.46 v.s. 0.48 [nmol 
ATP hydrolyzed / pmol ClpB hr], Fig. 5.13), which is another indication that the 
structural integrity of the mutant was retained. 
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Additionally, the ATPase activity of GI144ClpB was stimulated by poly-lysine, a 
potent activator of the ClpB ATPase activity, to similar extent as that of the ClpB95. 
Also, while casein increased the ATPase activity of ClpB95 over 12 times, only a 2-fold 
increase of the ATP hydrolysis rate was detected in case of the glycine insertion mutant 
(Fig. 5.13). 
Next, we tested the aggregate-binding capability and the chaperone activity of 
GI144ClpB. Interestingly, the ClpB variant with a modified N-domain linker region lost its 
ability to interact with aggregates of G6PDH in the presence of ATPγS (Fig. 5.14). This 
variant of ClpB was also inactive as a protein disaggregase, as shown by the G6PDH 
reactivation assay (Fig. 5.15). The chaperone activity could not be stimulated by 
additional presence of ClpB95, or ClpB80 in the reactivation assays. 
Thus, even slight variations in the length and composition of the linker region that 
connects the N-terminal domain to the rest of the molecule leads to defect in aggregate 
binding and processing. The fact that the oligomerization and the basal ATPase activity 
was not affected at all by the insertion of the additional glycines to the N-domain linker 
suggests that the AAA+ module is functional. It has been shown that casein and poly-
lysine affect the ATPase activity of ClpB by different mechanisms. The naturally 
unstructured casein acts more like a bona fide ClpB substrate and stimulates the 
ATPase of both AAA+ domains, while poly-lysine influences ATP hydrolysis by the 
second AAA+ domain (Strub et al., 2003).  
Discussion 
Biochemical properties of the two isolated ClpB isoforms were compared 
previously by several research groups (Park et al., 1993; Barnett et al., 2000; Chow et 
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al., 2005; Beinker et al., 2002). What has been possibly overlooked so far is the fact that 
both isoforms are produced and co-exist in bacterial cytoplasm. In this work, we 
discovered that ClpB achieves its full potential as an aggregate-reactivating chaperone 
through utilization of both isoforms and formation of hetero-oligomers. 
We showed that the N-terminally truncated isoform, ClpB80 becomes a less 
effective chaperone as the size of the aggregates increases (Fig.5.2). This is in 
agreement with previous results that showed that the N-terminal domain contributes 
significantly to the aggregate binding affinity of ClpB and becomes essential for 
mediating the interaction with large protein aggregates (Barnett et al., 2005). It has been 
also reported that in vivo under conditions that lead to increased protein misfolding 
(background of defective DnaK, that could suppress misfolding and aggregation) 
ClpB95 is a more effective chaperone than ClpB80 (Chow et al., 2005). 
Unexpectedly, we found that the chaperone system built from two ClpB isoforms 
works much better than the sum of its components (Figs. 5.3 and 5.4). We asked the 
question: where does the “excess” chaperone capability of ClpB95/ClpB80 come from, 
which is absent in either ClpB95 or ClpB80? As we have shown, the ClpB95/ClpB80 
hetero-oligomers do not have a significantly stronger aggregate binding capability than 
ClpB95 alone (Fig. 5.6 A, B and Fig. 5.7 A, B).  Moreover, the additional presence of the 
DnaK system did not increase the aggregate-binding affinity of ClpB homo-or hetero-
oligomers (Fig. 5.7 and Fig. 5.8). Also, in agreement with published data (Haslberger et 
al., 2007; Zietkiewicz et al., 2004), we found that the DnaK system has an important role 
upstream of the translocation, during the initial steps of the disaggregation process, as 
we could detect a slightly enhanced reactivation of G6PDH aggregates upon 
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preincubation with DnaK system, as compared to the preincubation with ClpB95 (Fig. 
5.9).  
We also observed that the hetero-oligomers do not hydrolyze ATP faster than the 
sum of their components (Fig. 5.10). Importantly, we can assume that the threading of 
substrates through the ClpB channel, which is an essential part of aggregate 
reactivation (Weibezahn et al., 2004) and is tightly coupled to the ATP consumption, 
does not occur faster with the ClpB95/ClpB80 hetero-oligomers than with the homo-
oligomers (Fig. 5.10B, C). This result suggests that the polypeptide threading is not the 
rate-limiting step of disaggregation and that another process, in which the hetero-
oligomers are superior to homo-oligomers, determines the overall rate of aggregate 
reactivation, as measured in Figs. 5.3 and 5.4. 
Sedimentation velocity experiments demonstrated that the self-association 
affinity of ClpB95 is lower than that of ClpB80 (see Fig. 5.5 C). This indicates that the 
formation of a full ring of the N-terminal domains is thermodynamically unfavorable.  
 Normal mode analysis revealed that the N-terminal domains in the homo-
hexamer formed by the full-length ClpB95 are significantly inhibited in their mobility as 
compared to the hetero-hexamer of ClpB95 and ClpB80 (Fig. 5.11C). This explains the 
results of the sedimentation velocity experiments, that the formation of hetero-oligomers 
of ClpB95 with ClpB80 is thermodynamically favorable over the formation of ClpB95 
homo-oligomers (see Fig. 5.5A, B) since the formation of an incomplete ring of the N-
terminal domains removes the “penalty” and restores the intrinsic mobility of the N-
terminal domain.  
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We have recently shown that conserved acidic residues at the surface of the N-
terminal domain of ClpB are involved in binding to aggregated proteins (Barnett et al., 
2005). We speculated that the mobility of the N-terminal domain might help ClpB seek 
and bind the exposed recognition sites on the surface of large protein aggregates. We 
have found now that even an incomplete ring of the N-terminal domains provides 
sufficient molecular contacts for interactions with an aggregated substrate and the 
binding efficiency of hetero-oligomers is similar to that of ClpB95 homo-oligomers. Thus, 
the hetero-oligomers do not possess excess aggregate binding capability (see Fig. 5.6 
and 5.7). Also, since there is no difference between ClpB95 and ClpB80 within the 
AAA+ modules, the efficiency of substrate threading through the central channel of the 
ClpB, does not increase in hetero-oligomers, as shown by our ATPase assays (Fig. 
5.10 B, C). 
We propose that there is an intermediate step between substrate binding and 
threading that is rate limiting for the disaggregation process and this step is supported 
by the mobility of the N-terminal domain of ClpB. In conclusion, the enhancement of the 
chaperone activity of ClpB95/ClpB80 hetero-oligomers is linked to an enhancement of 
mobility of the N-terminal domains which could support efficient substrate extraction 
from an aggregate and initiation of substrate translocation through the ClpB channel. 
Interestingly, in addition to the increased mobility of the N-terminal domains in the 
hetero-oligomers of ClpB, the normal mode analysis also detected a small stimulation of 
the C-terminal D2 small sub-domain mobility (Fig. 5.11C). This could suggest a linkage 
between the movements of the two domains with a possible role in coordinating the 
entrance and the exit of substrates into and from the central channel of ClpB. Thus the 
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N-domain mobility could influence the activity of ClpB also in an indirect way. At this 
point, we have no evidence for such mechanism. 
Based on the results obtained with a ClpB variant that contained a longer N-
domain linker region than ClpB95, it can be concluded that the mobility of the N-domain 
is optimized for the chaperone activity. The linker region (Fig. 5.12 A, B) that connects 
the N-domain of ClpB to the first AAA+ domain allows the movements of the N-terminal 
domain. We have found that even slight variation in the length and flexibility of the linker 
leads to a total loss of aggregate binding (Fig. 5.14) and solubilizing ability of ClpB (Fig. 
5.15). Also, the alteration of the linker length decreased the ability of α- casein to 
stimulate the ATPase activity of ClpB95, and not the basal or poly-lysine activated 
ATPase (Fig 5.13). Thus, it can be hypothesized that perhaps the linker insertions allow 
less controlled movements of the N-terminal domains, which may disable the substrate 
binding sites located in the N-terminal domain and at the entrance to the ClpB channel. 
Interestingly, similar results were obtained in case of another bacterial Clp 
ATPase, ClpA that also contains a mobile N-terminal domain and an internal translation 
initiation site at the C-terminal end of the N domain. ClpA also contains a 25 amino acid-
long linker region that connects the N-terminal domain to the rest of the protein and 
controls its mobility (Fig. 5.12B). It was found that the optimal function of ClpA in protein 
degradation requires an unaltered linker region, as shortening or elongation of the linker 
caused defects in ClpA activity (Cranz-Mileva et al., 2008). Recently, it has been found 
that the N-terminal domain of  another Clp ATPase, ClpX is likewise highly mobile and 
that the motions of the N-terminal domain are linked to the feeding of substrates into the 
ClpX channel (Thibault et al., 2006).  
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In conclusion, this study explains why the alternative translation initiation site in 
the ClpB gene has not been eliminated: E. coli produces two isoforms of ClpB to 
optimize activity of this chaperone through formation of hetero-oligomers. We showed 
that ClpB80 plays an important role in the ClpB function in spite of its low intrinsic 
substrate-binding capability. Since oligomer formation is an essential element of the 
mechanism of AAA+ ATPases, our results raise a possibility that the functionality of 
other AAA+ ATPases may be regulated by production of multiple protein isoforms and 
formation of hetero-oligomers. Moreover, since substrate insertion into the channel in 
the oligomeric ring is emerging as an underlying paradigm of the mechanism of AAA+ 
ATPases (Zolkiewski, 2006), our results suggest a common function for the N-terminal 
domains that are attached to the AAA+ modules, which is linked to substrate recognition 
and its delivery to the channel entry. The high mobility of the N-terminal domains may 
be essential for achieving efficient rates of substrate delivery. In the case of ClpB, 
formation of the hetero-oligomers of its two isoforms optimizes the functionality of the 
disaggregating chaperone by increasing the mobility of the N-terminal domains. 
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Figures 
 
Figure 5.1   Diagram of the two naturally-occurring isoforms of ClpB. 
Besides the full-length 95 kDa protein (ClpB95) an N-terminally truncated isoform 
(ClpB80) is also produced in E. coli cells. The truncated isoform is missing the 148 
residue-long N-terminal domain of the full-length ClpB. N-terminal domain (N) is colored 
in green, the two AAA+ modules, AAA-1 and AAA-2 (D1 and D2) are colored in purple 
and gray, respectively; the coiled-coil middle domain (M) is blue. The in vivo ratio of 
ClpB95/ClpB80 is ~ 2.  
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Figure 5.2   Reactivation of aggregated G6PDH in the presence of the ClpB/DnaK bichaperone system. 
Intermediate-size  (A) or large (B) aggregates of G6PDH were prepared by incubating 22 μM denatured G6PDH in buffer 
A for 1 min or 15 min, respectively, at 47 °C. After cooling on ice for 2 min, aggregates were diluted 8-fold into buffer A 
with 5 mM ATP containing either no chaperones (open circles), 5 μM DnaK, 1 μM DnaJ, 0.5μM GrpE (KJE, filled 
squares), KJE with 1.5 μM ClpB95 (full circles), or KJE with 1.5 μM ClpB80 (full triangles). After incubation at 30 °C for the 
indicated periods of time, aliquots were withdrawn and the G6PDH activity was measured as described in Materials and 
Methods.
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Figure 5.3   Reactivation of aggregated G6PDH by the combined action of 
ClpB95/ClpB 80 and the DnaK chaperone system. 
Aggregated G6PDH was prepared as described in Methods. The aggregates were 
diluted into buffer A with 6 mM ATP containing no chaperones (black crosses), 1 µM 
DnaK, 1 µM DnaJ, 0.5 µM GrpE (KJE) with 1.5 µM ClpB95 (red trace), KJE with 1.5 µM 
ClpB80 (green trace), KJE with 1 µM ClpB95 and 0.5 µM ClpB80 (cyan trace), KJE with 
0.75 µM ClpB95 and 0.75 µM ClpB80 (magenta), or KJE with 0.5 µM ClpB95 and 1 µM 
ClpB80 (blue trace).  After incubation at 30 °C for the indicated periods of time, aliquots 
were withdrawn and the G6PDH activity was measured as described in Materials and 
Methods. Insets show the G6PDH activity after 80 min vs. the molar fraction of ClpB80, 
fClpB80=[ClpB80]/([ClpB95]+[ClpB80]). 
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Figure 5.4   Reactivation of aggregated MDH by the combined action of ClpB95/ 
ClpB 80 and the DnaK chaperone system. 
Aggregated MDH was prepared as described in Methods. The aggregates were diluted 
into buffer B with 6 mM ATP containing either no chaperones (black crosses), 1 µM 
DnaK, 1 µM DnaJ, 0.5 µM GrpE (KJE) with 1.5 µM ClpB95 (red trace), KJE with 1.5 µM 
ClpB80 (green trace), KJE with 1 µM ClpB95 and 0.5 µM ClpB80 (cyan trace), KJE with 
0.75 µM ClpB95 and 0.75 µM ClpB80 (magenta), or KJE with 0.5 µM ClpB95 and 1 µM 
ClpB80 (blue trace). After incubation at 30 °C for the indicated periods of time, aliquots 
were withdrawn and the MDH activity was measured as described in Materials and 
Methods. Insets show the MDH activity after 120 min vs. the molar fraction of ClpB80 
fClpB80=[ClpB80]/([ClpB95]+[ClpB80]). 
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Figure 5.5   Sedimentation velocity analysis of ClpB95 and ClpB80. 
Ultracentrifugation was performed at 50,000 rpm and 20 °C in 50 mM Tris-HCl pH 7.5, 
0.2 M KCl, 20 mM MgCl2, 1 mM EDTA, and 2 mM β-mercaptoethanol. Apparent 
sedimentation coefficient distributions g(s*) vs. s*20,w in Svedbergs (S) were calculated 
from protein concentration profiles measured with absorption at 238 nm and are shown 
for 5 µM ClpB95 (A, red line), 2.5 µM ClpB80 (A, green line), 5 µM ClpB95 with 2.5 µM 
ClpB80 (B), 8 µM ClpB95 (C, red line), and 8 µM ClpB80 (C, green line). 
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Figure 5.6   Interaction of ClpB95 and ClpB80 substrate-trapping Walker B 
mutants with strongly aggregated G6PDH detected by gel filtration 
chromatography. 
Large aggregates of G6PDH were incubated with 15 µM ClpB95Trap (A), 15 µM 
ClpB80Trap (B), or 7.5 µM ClpB95Trap and 7.5 µM ClpB80Trap (C) for 5 min at 25 °C 
in buffer A with 2 mM ATP and injected onto the gel filtration column. 1-min elution 
fractions were analyzed by SDS-PAGE followed by Coomassie staining. Elution time 
(min) is indicated at the top of the figure. The arrows indicate the elution time of blue 
dextran and thyroglobulin; the position of the aggregates is marked with a red box.  (D) 
The amounts of ClpB95 and ClpB80 in gel filtration fractions eluting at 11, 12, and 13 
min (see panels A, B, C) were analyzed by band densitometry and corrected for the 
amount of G6PDH in each fraction. Shown are the amounts of ClpB95 (from panel A, 
red bars) and total amounts of ClpB95+ClpB80 (from panel C, green bars). The relative 
amounts of ClpB80 and ClpB95 bound to G6PDH in panel C are also shown (circles, 
right axis). 
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Figure 5.7   Interaction of ClpB95 and ClpB80 substrate-trapping Walker B 
mutants with aggregated substrates as detected by filter assay. 
2.7 µM aggregated G6PDH (A) or 3 µM MDH (B) were incubated in buffer A in presence 
of 5 mM ATP with 1.5 µM ClpB95Trap (95, lanes 3, 4), 1.5 µM ClpB80Trap (80, lanes 
5,6) or 0.75 µM ClpB95Trap and 0.75 µM ClpB80Trap (95+80, lanes 7,8), without (lanes 
3, 5, 7)or with 1µM DnaK, 1 µM DnaJ, and 0.5 µM GrpE (KJE, lanes 4,6,8) for 10 min at 
30 °C with mixing at slow speed. Control samples containing 2.7 µM aggregated 
G6PDH (A) or 3 µM aggregated MDH (B) were also incubated under similar conditions 
in presence of ATP without (lane 1) and with the DnaK system (lane 2) in addition to the 
controls with 2.7 µM native G6PDH (A) or 3 µM native MDH (B) in presence of 0.75 µM 
ClpB95Trap and 0.75 µM ClpB80Trap without (lane 9) or with the DnaK system (lane 
10). The solutions (35µl) were passed through a 0.1 μm filter and the fraction retained 
on the filter was eluted with SDS buffer and analyzed by SDS-PAGE, followed by 
Coomassie blue staining. 
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Figure 5.8   Interaction of ClpB95 with aggregated G6PDH upon preincubation 
with the DnaK chaperone system. 
G6PDH aggregates were incubated in buffer A in presence of 5 mM ATP with 
DnaK/DnaJ/GrpE (KJE, lane 13) or with ClpB95 (lane 14) for 10 min at 30 ˚C after 
which the missing chaperones (ClpBTrap or KJE, respectively) were added and 
incubated for an additional 10 min. Aggregated G6PDH was also incubated in presence 
of ATP (lanes 5, 6) with KJE (lanes 7, 8), ClpB95Trap (lanes 9, 10) or mixtures of KJE + 
ClpB95Trap (lanes 11, 12) for 10 min (lanes 5, 7, 9, 11) or 20 min (lanes 6, 8, 10, 12). In 
case of the control samples native G6PDH was similarly incubated in presence of ATP 
(lane1) with KJE (lane 2), ClpB95Trap (lane 3) or mixtures of KJE + ClpB95Trap (lane 
4) for 20 minutes. The concentrations used were: 4 μM native or aggregated G6PDH, 
1.5 μM ClpB95Trap, 1µM DnaK, 1 µM DnaJ, 0.5 µM GrpE. After incubation 35 μl was 
applied to the filter units and the aggregate containing fractions were separated as 
described in Materials and Methods. The results of the SDS-PAGE are shown. 
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Figure 5.9   Reactivation of aggregated G6PDH upon preincubation with DnaK 
chaperone system. 
The aggregates were diluted into buffer A with 6 mM ATP containing 1 µM DnaK, 1 µM 
DnaJ, 0.5 µM GrpE (KJE) (blue squares) and 1.5 µM ClpB95 (red circles) and after 10 
min incubation at 30 °C the missing chaperones were added at time 0 of the reactivation 
assay. At the indicated periods of time, aliquots were withdrawn and the G6PDH activity 
was measured as described in Materials and Methods. Averages of two measurements 
are shown for the preincubated samples. Controls samples were also included that 
contained aggregated G6PDH without chaperones (magenta open triangles) or with 1 
µM DnaK, 1 µM DnaJ, 0.5 µM GrpE (KJE) (black X-es). 
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Figure 5.10   ATPase activity of ClpB95 and ClpB80. 
The rate of ATP hydrolysis catalyzed by ClpB95 and ClpB80 at 37 °C was measured as 
the function of the molar fraction of ClpB80 (fClpB80) without activators (A), with 5 μM 
peptide B1 (B), or with 0.2 mg/ml α-casein (C). Inorganic phosphate production from 
ATP was determined in the presence of 30 pmol ClpB (A), 15 pmol ClpB (B), or 6 pmol 
ClpB (C) after 15 minute. (D) Inorganic phosphate production was also measured during 
the reactivation of aggregated G6PDH (2.7 µM) with 1 µM DnaK, 1 µM DnaJ, 0.5 µM 
GrpE (KJE) and 1.5 µM ClpB95 (red circles), KJE with 1.5 µM ClpB80 (green circles), 
KJE with 1 µM ClpB95 and 0.5 µM ClpB80 (cyan circles), KJE with 0.75 µM ClpB95 and 
0.75 µM ClpB80 (magenta circles), or KJE with 0.5 µM ClpB95 and 1 µM ClpB80 (blue 
circles). 
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Figure 5.11   Domain mobility in the homo-hexamer of ClpB95 and hetero-
hexamer of ClpB95/ClpB80. 
Elastic normal mode analysis was performed on the iMolTalk hexameric model of T. 
thermophilus ClpB (Diemand and Lupas, 2006) using the ElNemo server (Suhre and 
Sanejouand, 2004). The α-Carbon B-factors computed from the first 100 normal modes 
of a ClpB95 subunit located in a homo-hexamer or hetero-hexamer containing 3 ClpB95 
and 3 ClpB80 subunits. The iMolTalk hexameric model of ClpB homo-hexamer (A) or 
hetero-hexamer (B) are colored by B-factors (values increase from dark blue to red). (C) 
Plot of the normalized α-Carbon B-factors of the homo-hexamer (green) and the hetero-
hexamer (red). 
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Figure 5.12   Localization and sequence of the N-terminal flexible linker. 
Ribbon representation of the E. coli ClpB95 monomer model (A). The 14 residue-long 
linker that connects the N-terminal domain of ClpB to the first AAA+ module is colored in 
red. Parts of the N-terminal domain (green), the first AAA+ module (orange) and the tip 
of the middle domain (blue) are also visible. (B) Sequence of the E. coli ClpB95  N-
domain linker and that of GI144ClpB compared to the sequence of the E. coli ClpA 
linker. The red arrow indicates the place where four Gly residues were inserted; the first 
residue of the AAA-1 module is colored in blue. 
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Figure 5.13   ATPase activity of GI144ClpB. 
The rate of ATP hydrolysis was measured for ClpB95 and GI144ClpB glycine insertion 
mutant, in the absence of other polypeptides (red bars), in the presence of 0.1 mg/ml κ-
casein (green bars), or with 0.04 mg/ml poly-L-lysine (yellow bars) after a 15 min 
incubation at 37 ˚C in presence of 2.5 μg ClpB in the absence of stimulators and 0.25 
μg ClpB in presence of κ-casein or poly-L-lysine. 
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Figure 5.14   Interaction of GI144ClpB with aggregated G6PDH. 
1.5 μM ClpB95 and GI144ClpB were incubated with native (lanes 1-4) or with 
aggregated G6PDH (3 μM) (lanes 5-8) without nucleotides (lanes 1-2, 5-6) or with 5 mM 
ATPγS (lanes 3-4, 7-8).  The solutions (35 μl) were passed through a 0.1-μm filter.The 
result of the SDS-PAGE is shown for the fractions retained on the filter and 
subsequently solubilized with an SDS buffer. 
 
 
 
 
 
 
 146
Figure 5.15   Reactivation of aggregated G6PDH in the presence of GI144ClpB and 
the DnaK chaperone system. 
Aggregated 3 μM G6PDH was incubated in buffer A in presence of  5 mM ATP without 
chaperones (magenta cross) or with 1 μM DnaK, 1 μM DnaJ, 0.5 μM GrpE (KJE) and 
1.5 μM ClpB95 (black squares), KJE with 1.5 μM GI144ClpB (red circles), KJE with 0.75 
μM ClpB95 + 0. 75 μM GI144ClpB (green triangles), and KJE with 0.75 μM ClpB80 + 0. 
75 μM GI144ClpB (cyan diamonds). After incubation at 30 °C for the indicated time, the 
G6PDH activity was measured as described in Methods.  
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CHAPTER 6 - Design and production of new fluorescent tools 
for mapping the ClpB-substrate interaction sites 
 
Introduction 
As the studies on the functionality of the ClpB95/ClpB80 hetero-oligomers 
exemplify, the events preceding the translocation of polypeptides through the central 
channel of the ClpB oligomer have a major, but so far not well described, role in the 
overall protein disaggregation mediated by ClpB. Based on our results obtained with the 
hetero-oligomers of ClpB, we postulated that the extraction of polypeptides from the 
aggregate and their insertion into the ClpB channel represent the rate-limiting 
intermediate step that occurs between the initial substrate recognition/binding and the 
translocation step. Currently, it is not known how ClpB is able to selectively recognize 
aggregated substrates over the correctly folded native proteins.  
It has been proposed that molecular chaperones specifically recognize 
aggregation-prone hydrophobic sequences that are capped by positively charged 
gatekeeper residues (Chapter 1) (Rousseau et al., 2006). Indeed, peptide-binding 
studies revealed that ClpB preferentially binds to peptides that are enriched in positively 
charged and aromatic residues (Schlieker et al., 2004). Conserved residues, a tyrosine 
and two acidic residues, located on the flexible loops that line the entrance to the ClpB 
channel, were shown to be involved in substrate binding (Schlieker et al., 2004). We 
have shown that a pair of acidic residues located in the N-terminal domain of ClpB could 
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also support binding of aggregated proteins (Barnett et al., 2005). Moreover, we 
propose that the conserved residues located on the flexible loops that line the entrance 
to the ClpB channel are involved in the initiation of substrate translocation through the 
ClpB channel rather than in the initial event of aggregate recognition (as described in 
Chapter 1). Existing data suggests that the N-terminal domain (Chapter 5) and the 
coiled-coil middle domain of ClpB, as well as the DnaK system (Weibezahn et al., 2004; 
Haslberger et al., 2007), all play important roles in extraction of substrates from 
aggregates and insertion into the ClpB channel for translocation.  
Thus, in order to dissect the overall mechanism of ClpB-mediated aggregate 
reactivation, it is crucial to characterize the initial interaction between ClpB and 
aggregated substrates and to investigate the mechanisms that control the substrate 
insertion into the ClpB channel. We intend to use fluorescently labeled ClpB and 
aggregated substrate to study both the initial interaction event and the subsequent 
extraction/insertion step of the disaggregation process by fluorescence resonance 
energy transfer (FRET). FRET is based on the transfer of the excited state energy from 
a donor (D) fluorophore, to an acceptor (A) molecule without the emission of a photon. 
This “radiationless” transfer of energy occurs only if the absorption spectrum of the 
acceptor molecule overlaps with the emission spectrum of the donor. The efficiency of 
FRET however, is influenced by the distance between the donor and the acceptor 
among other factors, and thus it is often used to detect protein-protein interactions. 
This part of the dissertation describes ClpB variants designed and produced for 
labeling with florescent dyes. It also presents preliminary data, which confirms that 
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FRET can be successfully used to detect interaction between ClpB and model 
substrates.  
Materials and Methods 
Mutagenesis and protein purification 
 Cys-free ClpB (Cys-less ClpB) as well as the single-Cys variants of ClpB and 
their substrate trapping versions were produced by site-directed mutagenesis as 
described in Chapter 3. After the purification the single-Cys variants N104C ClpB, 
N104C ClpBTrap and V246C ClpBTrap were dialyzed against a buffer that contained 
TCEP (Tris(2-carboxyethyl)phosphine hydrochloride; Invitrogen) as a reducing agent 
instead of the commonly used DTT (50 mM Tris/HCl pH 7.5, 0.2 M KCl, 20 mM MgCl2, 
1mM EDTA, 5 mM TCEP, 10% glycerol). This was necessary to allow for efficient 
labeling of cysteines with the thiol-reactive probe, because TCEP, unlike DTT and β-
mercaptoethanol, does not contains thiols and does not have to be removed prior to 
labeling. 
Model substrates and labeling reagents 
FITC-casein (fluorescein isothiocyanate-casein) and к-casein were obtained from 
Sigma-Aldrich (St. Louis, MO). Fluorescent probes used for labeling: IAEDANS (5-((((2-
iodoacetyl)amino)ethyl)amino)naphthalene-1-sulfonic acid) and F5M (fluorescein-5-
maleimide) were purchased from Invitrogen (formerly Molecular Probes).  
Peptide B1 (2.54 kDa) was synthesized at the Kansas State University Biotech 
Core Facility. The peptide was solubilized in 5 % acetic acid and purified by reverse 
phase HPLC (RP-HPLC) on a 15 cm C12 column (Synergi Max-RP) equilibrated with 
10% acetonitrile (ACN). The peptide was eluted at 0.8 ml/min when the organic gradient 
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reached ~23 % of ACN. The fractions containing peptide B1 (0.5 ml) from several runs 
were combined and lyophilized. The lyophilized sample containing the purified peptide 
B1 was dissolved in buffer containing 50 mM Tris/HCl pH 7.5 and 5 mM TCEP. The 
concentration was determined by measuring the absorbance at 280 nm and using the 
calculated extinction coefficient (ε (280 nm) = 7115 M -1 cm -1). 
 Protein and peptide labeling 
N104C ClpBTrap, V246C ClpBTrap, and Cys-less ClpB were labeled separately 
with IAEDANS, while peptide B1 was labeled with F5M (fluorescein) by using previously 
published methods (Rye, 2001) and the protocol provided by Invitrogen. ClpB solutions 
were diluted to 100 μM with labeling buffer (50 mM Tris/HCl pH 7.5, 0.2 M KCl, and 5 
mM TCEP) to a final volume of 2.5 ml. IAEDANS stock solution (50 mM) was prepared 
immediately prior to use by dissolving the dry powder in DMF (N, N-
dimethylformamide). Approximately a 10-fold molar excess of the label was added to 
the protein solution (50 μl IAEDANS from the 50 mM stock solution) drop wise while 
stirring the mixture in the dark. The reaction was allowed to proceed for 4 hours in the 
dark at 25˚ C (with constant stirring), after which the reaction was quenched by addition 
of 10 mM β-mercaptoethanol. Following the labeling procedure the proteins were 
separated from the unreacted dye on a Sephadex G-25 gel filtration column (PD-10 
desalting column; GE Healthcare) equilibrated with 50 mM Tris/HCl pH 7.5, 0.2 M KCl, 
20 mM MgCl2, 1 mM EDTA, and  1 mM DTT. The proteins eluted from the gel filtration 
column were dialyzed extensively against a buffer containing 50 mM Tris/HCl pH 7.5, 
0.2 M KCl, 20 mM MgCl2, 1 mM EDTA, 1 mM DTT, and 10 % glycerol (dialysis buffer). 
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The concentration of the proteins was determined by measuring the absorbance at 280 
nm. 
For the labeling of the purified peptide B1, 40 mM stock solution of fluorescein-5-
maleimide was prepared freshly by dissolving the dry powder in DMF. The labeling 
procedure was similar to the procedure used to label ClpB with IAEDANS except 
peptide B1 was diluted to 90 μM with the labeling buffer without KCl (50 mM Tris/HCl pH 
7.5, 5 mM TCEP) and a 20-fold excess of F5M over the peptide was used during 
labeling (for 2 mM F5M in the 800 μl final reaction volume). Instead of using gel filtration 
for the removal of the unreacted dye, the reaction mixture was extensively dialyzed 
against the dialysis buffer without glycerol and the labeled peptide was further purified 
on RP-HPLC, lyophilized and dissolved in buffer containing 50 mM Tris/HCl pH 7.5, 20 
mM MgCl2, 1 mM EDTA, and 1 mM DTT.  
ATP-dependent self association 
Proteins (wt ClpB, Cys-less ClpB, N104C ClpB, N104C ClpBTrap and V246C 
ClpBTrap, as well as the IAEDANS labeled versions of  Cys-less ClpB, N104C 
ClpBTrap and V246C ClpBTrap were diluted to 2 mg/ml in running buffer (50 mM 
Tris/HCl pH 7.5, 0.2 M KCl, 20 mM MgCl2, 1 mM EDTA, 1 mM DTT). For each run 20 μl 
was injected onto a 25 cm (2.4 ml) Superose 6 PC 3.2/30 column (GE Healthcare, 
formerly Amersham Biosciences) equilibrated with running buffer (monomeric condition) 
or with running buffer supplemented with 2 mM ATP (oligomeric condition). The runs 
were performed at 0.05 ml/min at room temperature with a Shimadzu HPLC LC10ATvp 
equipped with M10Avp diode-array detector. The absorption was recorded at 290 nm. 
 152
Thyroglobulin (670 kDa), apoferritin (443 kDa), alcohol dehydrogenase (150 kDa), BSA 
(66 kDa) and cytochrome C (12.4 kDa) were used as protein standards (from Sigma). 
ATPase activity 
The rate of ATP hydrolysis was measured after 15 min incubation at 37˚C in 100 
mM Tris/HCl pH 8, 10 mM MgCl2, 5 mM ATP, 1 mM EDTA, 1 mM DTT by using the 
malachite green method (Hess and Derr, 1975; Lanzetta et al., 1979). Assay solutions 
contained 2.5 μg ClpB in case of the basal ATPase measurements and 0.25 μg ClpB in 
case of the casein activated ATPase measurements (0.1 mg/ml к-casein). Peptide B1 
stimulated ATPase activity was measured for 2.5 μg wt ClpB in absence or in presence 
of 10 μM purified peptide B1.  
Fluorescence spectroscopy 
Fluorescence spectra were measured with a Cary Eclipse spectrofluorimeter 
(Varian) using a 1-cm quartz fluorescence cuvette. The excitation wavelength was set at 
336 nm and the emission spectrum was recorded from 350 nm to 650 nm. Both 
emission and excitation slits were set to 5 nm and scanning was performed at low 
speed. All experiments were conducted at room temperature in buffer containing 50 mM 
Tris/HCl pH 7.5, 0.2 M KCl, 20 mM MgCl2, 1 mM EDTA, 1 mM DTT.  Protein solutions 
were mixed with labeled or non-labeled model substrates without nucleotides or with 3 
mM ATP; the spectrum was recorded after 5 minute incubation at room temperature. 
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Results and Discussion 
Design and characterization of the Cys variants of ClpB 
As described above the overall goal of the FRET studies is to characterize the 
initial interaction event between ClpB and aggregated proteins by following the 
interaction-induced responses of small fluorescent probes positioned at selected 
locations within the putative substrate binding sites in ClpB and at selected sites of an 
aggregated substrate. As a first step towards this goal we designed mutated versions of 
ClpB that allow for the coupling of exogenous fluorescent dyes to specific sites in ClpB. 
The thiol side-chain of the cysteines are commonly used as a site for the labeling with 
thiol-reactive fluorescent dyes. E. coli ClpB contains three Cys residues: Cys94 located 
in the N-terminal domain of ClpB, Cys310 located  in the large sub-domain of the first 
AAA+ module (D1 large) and Cys615  within the large sub-domain of the second AAA+ 
domain (D2 large) (see Fig. 6.1). None of these endogenous Cys residues are located 
in the proximity of the putative substrate binding sites of ClpB and thus are not useful in 
FRET based experiments.  
In order to specifically label selected sites in ClpB we produced a Cys-free 
version of ClpB (Cys-less ClpB) by mutating all three endogenous Cys residues to Ala. 
Based on the available crystal structures we chose two residues, located near the 
substrate binding sites of ClpB, for the subsequent introduction of single Cys residues. 
The first site selected for replacement with Cys, Asn104, is located on the surface of the 
N-terminal domain in the vicinity of the three residues: Thr7, Asp103 and Glu109, which 
were shown to support chaperone activity of ClpB (Liu et al., 2002) and thus were 
proposed to define a substrate binding site for aggregates (Barnett et al., 2005) (Fig. 6.1 
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and Fig. 6.2). The second site chosen for the replacement with Cys residue; Val246, is 
located in the first AAA+ module, in proximity of the flexible loop that defines the 
entrance to the ClpB channel (Fig.6.1). As mentioned previously, the conserved Tyr251 
located on the flexible channel loop, as well as two neighboring acidic residues (Glu254 
and Glu257) were also proposed to contribute to the substrate binding site of ClpB 
(Schlieker et al., 2004). As Fig. 6.3 illustrates, the Val246 selected for replacement with 
Cys and for the subsequent labeling with the fluorescent dye is positioned below the 
flexible central loop of the D1 large sub-domain and this way has a lower chance to 
disturb substrate binding.  Aside from the N104C or the V246C mutations introduced in 
the Cys-less ClpB (C94A/C310A/C615A) we further mutated the conserved Walker B 
residues in both AAA+ modules (E279Q/E678Q) to produce the trap versions of ClpB 
(N104C ClpBTrap and V246C ClpBTrap) that form stable interaction with substrates in 
presence of ATP (as described in Chapter 4).  
Consequently, we purified a total of four ClpB variants: Cys-less ClpB, N104C 
ClpB, N104C ClpBTrap (C104ClpB*) and V246C ClpBTrap (C246ClpB*) and followed 
the nucleotide-induced self association by gel filtration chromatography. We have found 
that despite of a large number of mutations introduced in wt ClpB sequence (a total of 
six mutations for the Trap versions of the single-Cys variants) the corresponding 
proteins were able to form wild type ClpB-like oligomers in presence of ATP (Fig. 6.4). 
Since the trap versions of ClpB are unable to hydrolyze ATP (Weibezahn et al., 2003) 
we only measured the ATPase activity of N104C ClpB and found that this ClpB variant 
retained both the basal and the casein stimulated ATPase activity of the wt ClpB after 
the quadruple cysteine mutation (Fig. 6.5).  
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Labeling of ClpB and its pseudo-substrate with fluorescent dyes  
For the FRET experiments we decided to use the IAEDANS (5-((((2-iodoacetyl) 
amino)ethyl)amino)naphthalene-1-sulfonic acid) as energy donor and fluorescein as 
energy acceptor. The IAEDANS/fluorescein is a commonly used FRET pair since the 
emission spectrum of IAEDANS (emission maximum at 490 nm) overlaps with the 
absorption spectrum of fluorescein. The Forster radius (the distance at which FRET is 
50% efficient) for IAEDANS/fluorescein pair is approximately 46 Å.  
The trap versions of the single-Cys ClpB variants C104ClpB* and C246ClpB* 
were labeled with IAEDANS as described in Materials and Methods. In order to 
establish that the fluorescent probes were conjugated to the intended sites and not to 
nonspecific sites, we also attempted to label the Cys-less ClpB with IAEDANS as a 
negative control. As Fig. 6.6 illustrates, both C104ClpB* and C246ClpB* were 
successfully labeled with IAEDANS as they show the characteristic fluorescence 
emission spectra with a maximum intensity at ~490 nm when excited at 336 nm. But 
most importantly, only a very low fluorescence corresponding to IAEDANS was 
observed in case of the Cys-less ClpB after labeling. This result confirms that IAEDANS 
label was selectively targeted to the single engineered Cys residues located either in 
the N-terminal domain or at the entrance to the ClpB channel. By comparing the protein 
absorbance at 280nm to the IAEDANS absorbance at 336 nm we estimated that the 
labeling yield for C104ClpB* was ~30 %, as for C246ClpB* was ~50 %. Gel filtration 
confirmed that the labeled proteins were not affected in their ability to form oligomers in 
presence of ATP (Fig. 6.7). 
We have also used a 21 amino acid-long positively charged “peptide B1” as 
pseudo-substrate for ClpB. Peptide B1 (AHAWQHQGKTLFISRKTYRIC) was originally 
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identified by Bukau and coworkers through peptide scans and it was shown to bind to 
the central pore of the hexameric ClpB (Schlieker et al., 2004). Peptide B1 was 
synthesized and the crude product was purified on a reversed-phase column. As 
expected, the purified peptide B1 was able to stimulate the ATPase activity of ClpB (Fig. 
6.8). The single Cys residue located at the C-terminal end of peptide B1 was labeled 
with fluorescein-5-maleimide by using published procedures (Rye, 2001) as described 
in Materials and Methods. The labeled peptide was further purified by reversed-phase 
HPLC and used in FRET experiments. 
 Detection of ClpB-model substrate interaction by FRET  
The ATP-dependent interaction between donor labeled ClpB and acceptor 
labeled model substrate can be detected by FRET as a decrease in the emission 
intensity of the donor (IAEDANS) and a concomitant increase in the emission intensity 
of the acceptor (fluorescein). As mentioned above the IAEDANS emission band has 
maximum intensity at 490 nm when excited at 336 nm, while the maximum intensity of 
fluorescein occurs at ~515 nm. As shown in Fig. 6.9 for the individual and combined 
spectras of the IAEDANS-labeled ClpB variants (Fig 6.9A and Fig. 6.9B for IAEDANS-
C104ClpB* and IAEDANS-C246ClpB*, respectively) and the fluorescein-labeled peptide 
B1, besides the overlap between the emission spectrum of IAEDANS (400 nm-650 nm) 
and the absorption spectrum of fluorescein, the emission spectrum of IAEDANS 
overlaps significantly also with the emission spectrum of fluorescein (480 nm-650 nm). 
Due to this overlap, the FRET-induced decrease in the IAEDANS emission may hinder 
the observation of the increase in the emission intensity of fluorescein. However, 
fluorescein shows less interference with the emission spectrum of IAEDANS around the 
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wavelength corresponding to the maximum IAEDANS emission intensity (450 nm-480 
nm). Based on these observations we focus on the decrease in the donor intensity as 
an indication of energy transfer between ClpB and the bound substrate.  
As the combined fluorescence emission spectrum of IAEDANS-labeled 
C104ClpB* and fluorescein-labeled peptide B1 shown in Fig. 6.10 (left panel) illustrates, 
we observed a decrease in the intensity of the IAEDANS/donor peak ~475 nm and an 
increase in the intensity of the fluorescein/acceptor peak at 515 nm upon addition of 
ATP. This is an indication that energy transfer occurred between the IAEDANS label 
conjugated to Cys104 and the fluorescein conjugated to the C-terminal end of the model 
peptide as a result of their ATP-dependent interaction. Importantly, this decrease in the 
IAEDANS fluorescence was not detected when the non-labeled version of the peptide 
B1was used in presence of ATP (Fig. 6.10, right panel). FRET was also detected 
between the IAEDANS label conjugated to Cys246 and fluorescein-peptide B1 as 
shown in Fig. 6.11 (left panel), although the FRET effect was observed only as a 
decrease of the donor peak around 475 nm. The ratio of ClpB/peptide was the same as 
in case of the N-terminally conjugated label, but due to the higher labeling efficiency of 
C246ClpB* (i.e. higher fluorescence)  and the above described effect of the decrease in 
the IAEDANS fluorescence on the fluorescence peak of the acceptor, the increase in 
the acceptor fluorescence intensity is not observed. Similarly to C104ClpB*, the addition 
of ATP to the C246ClpB* and non-labeled peptide B1 did not cause a decrease in the 
IAEDANS intensity (Fig. 6.11, right panel), indicating that the effect observed with the 
labeled ClpB and substrate is a consequence of the energy transfer that occurs as a 
result of their interaction.  
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Finally, we have also followed binding of fluorescein isothiocyanate-casein 
(FITC-casein) to the two single-Cys variants of ClpB labeled with IAEDANS. The ATP-
induced interaction with IAEDANS-labeled C104ClpB* (Fig. 6.12, left panel) or 
C246ClpB* (Fig. 6.13, left panel), and the corresponding FRET signal was also 
observed in case of this unstructured model substrate. In order to detect the increase in 
the acceptor fluorescence with the IAEDANS label conjugated to Cys246, we used 
higher FITC-casein/ClpB ratio (Fig. 6.13) than for the IAEDANS conjugated to Cys104 
(Fig. 6.12). Again, there was no decrease in the donor fluorescence when the non-
labeled casein was incubated with the IAEDANS-labeled C104ClpB* (Fig. 6.12, right 
panel) or IAEDANS-labeled C246ClpB* (Fig. 6.13, right panel) in presence of ATP.  
In conclusion, we have shown that we were able to engineer single-Cys variants 
of ClpB that retained wild type ClpB-like oligomerization properties (Fig. 6.7) and 
remained active as ATPases (as seen for the non-trap version of N104C ClpB, Fig. 6.5). 
We have also successfully labeled the trap version of ClpB with IAEDANS at two 
separate locations in the vicinity of putative substrate binding sites of the N-terminal 
domain and of the central pore region of the hexameric ClpB (C104ClpB* and 
C246ClpB*, respectively). Moreover, we have demonstrated that FRET can be 
observed between ClpB and model pseudo-substrates in the presence of ATP (Figs. 
6.10 through 6.13). Importantly, the relative efficiency of FRET observed throughout our 
experiments is comparable to the FRET efficiency detected in case of the GroEL-GroES 
interaction (Rye, 2001). The preliminary experiments presented in this chapter show 
that it is feasible to use FRET as a proximity sensor to detect ClpB-substrate interaction.  
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It will be worth experimenting with other FRET donor-acceptor pairs that have a 
better separation between the emission spectrum of the donor and the acceptor. For 
example the existing single-Cys variants of ClpB as well as substrate proteins could be 
labeled with the highly superior thiol-reactive Alexa Fluor dyes like Alexa Fluor 350 
(donor) and Alexa Fluor 488 (acceptor). This FRET pair has also a Forster radius ~50 Å, 
but there is only a minimal overlap between the fluorescence emission spectra of the 
two dyes. Alexa Fluor dyes can be also used in conjunction with the nonfluorescent 
acceptors such as dabcyl and the QSY dyes (http://probes.invitrogen.com/handbook/). 
Although so far we used only soluble pseudo-substrates in the FRET 
experiments, future studies will be focused on labeling the G6PDH aggregates (or 
aggregating labeled G6PDH) at selected locations with FRET acceptor dyes in an 
attempt to identify the sites on aggregates that are involved in the initial binding to ClpB, 
before the substrate insertion and the subsequent translocation step occurs. 
Additionally, the substrate trapping ClpB variant with IAEDANS donor conjugated to the 
single Cys residue located at the entrance to the ClpB channel (IAEDANS-C246ClpB*) 
could be used to investigate the mechanism that controls the access of fluorescein 
labeled aggregated substrates to the ClpB pore site by following the kinetics of FRET 
development with stopped flow-fluorescence experiments. 
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Figures 
 
Figure 6.1   Positions of amino acid mutations produced for this study. 
The diagram shows the domain organization of E. coli ClpB. Three endogenous Cys 
residues located in the N-terminal domain (N, green), in the large sub-domain of the first 
AAA+ module (D1, orange), and in the large sub-domain of the second AAA+ module 
(D2, orange), were mutated to Ala in order to produce a Cys-less ClpB 
(C94A/C310A/C615A). Double Walker B mutations were further introduced in the Cys-
less ClpB (E279Q/E678Q). Single-Cys variants used for fluorescent labeling contained 
Cys at position Asn104 in the N-terminal domain of ClpB or at place of Val246 in the D1 
large sub-domain. The middle domain is colored in blue (M) while the small sub-
domains of D1 and D2 are colored in magenta. 
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Figure 6.2   Location of the labeling site in the N-terminal domain. 
The ribbon structure of the isolated N-terminal domain of E. coli ClpB (1khy) 
(Li and Sha, 2003) with indicated locations of the putative substrate binding site defined 
by Thr7 (magenta), Asp103 (red) and Glu109 (yellow) (Liu et al., 2002). Asn104 located 
in proximity of the substrate binding residues and selected for replacement with Cys is 
shown in green. 
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Figure 6.3   Location of the labeling site at the entrance to the ClpB channel. 
Ribbon representation of the isolated D1 large sub-domain of E.coli ClpB (1jbk) (Li and 
Sha, 2002) showing the conserved substrate-binding Tyr251 residue (red) of the flexible 
pore loop that lines the entrance to the ClpB translocating channel (Schlieker et al., 
2004b; Barnett et al., 2005). Val246 selected for replacement with Cys is located below 
the conserved pore loop is shown in green. The dashed line indicates the position of the 
ClpB channel axis. 
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Figure 6.4   Oligomerization of wt ClpB and the various Cys mutants. 
Wt ClpB, Cys-less ClpB, N104C ClpB as well as the substrate trap versions of the 
single-Cys variants of ClpB C104ClpB* (N104C ClpBTrap) and C246ClpB* (V246C 
ClpBTrap) were run on a Superose 6 gel filtration column at 0.05 ml/min without 
nucleotides (solid black lines) or in presence of 2 mM ATP (broken red lines). The 
elution times of four molecular weight standards (thyroglobulin (670 kDa), apoferritin 
(443 kDa), alcohol dehydrogenase (150 kDa), BSA (66 kDa)) are indicated with black 
circles in the upper panel. 
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Figure 6.5   ATPase activity of N104C ClpB. 
The rate of ATP hydrolysis was measures at 37 ˚C for wt ClpB and N104C ClpB 
(C94A/C310A/C615A/N104C) without an activator (basal ATPase, red bars) and in 
presence of 0.1 mg/ml к-casein (hatched bars). The averages of three measurements 
are shown with the standard deviation. 
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Figure 6.6   Fluorescence emission spectra of the single-Cys variants of ClpB and 
the Cys-less ClpB after labeling with IAEDANS. 
Left panel shows Trp fluorescence spectrum of the IAEDANS labeled: C104ClpB* (blue 
thin line), C246ClpB* (red thick line), and Cys-less ClpB (black dotted line) obtained with 
excitation at 290 nm. The right panel shows the IAEDANS fluorescence spectrum 
obtained with excitation at 336 nm. The total concentration of the various proteins was 5 
μM.  
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Figure 6.7   Oligomerization of wt ClpB and the various Cys mutants after 
IAEDANS labeling. 
Wt ClpB and the IAEDANS labeled Cys-less ClpB, as well as the substrate trap 
versions of the single-Cys variants of ClpB C104ClpB* (N104C ClpBTrap) and 
C246ClpB* (V246C ClpBTrap) were run on a Superose 6 gel filtration column at 0.05 
ml/min without nucleotides (solid black lines) or in presence of 2 mM ATP (broken red 
lines). The elution times of four molecular weight standards (thyroglobulin (670 kDa), 
apoferritin (443 kDa), alcohol dehydrogenase (150 kDa), BSA (66 kDa)) are indicated 
with black circles in the upper panel. 
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Figure 6.8   ATPase activity of wt ClpB in presence of peptide B1. 
The rate of ATP hydrolysis was measured at 37 ˚C for wt ClpB (0.5 μM monomeric) in 
absence or in presence of the purified peptide B1 (10 μM). The averages of three 
measurements are shown with the standard deviation.  
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Figure 6.9   Emission spectra of the donor labeled ClpB variants and acceptor 
labeled model substrate used for FRET. 
Fluorescence spectra of 5 μM (0.8 μM hexameric) IAEDANS labeled ClpB (IAEDANS-
C104ClpB* shown in panel A or IAEDANS-C246ClpB* shown in panel B) and 0.8 μM 
fluorescein-peptideB1 individually and mixed together. Excitation wavelength was set at 
336 nm in all cases. 
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Figure 6.10   FRET between IAEDANS labeled C104ClpB* and fluorescein labeled 
peptide B1. 
Left Panel: fluorescence emission spectra of 0.8 μM (hexameric) IAEDANS-C104ClpB* 
(D; donor) and 0.8 μM fluorescein-peptide B1 (A; acceptor) without nucleotides (D + A) 
or with 3 mM ATP (D + A + ATP). Right panel: fluorescence emission spectra of 0.8 μM 
(hexameric) IAEDANS-C104ClpB* (D; donor) and 0.8 μM non-labeled peptide B1 (pB1) 
without nucleotides (D + pB1) or with 3 mM ATP (D + pB1 + ATP). Excitation 
wavelength was set at 336 nm. 
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Figure 6.11   FRET between IAEDANS labeled C246ClpB* and fluorescein labeled 
peptide B1. 
Left Panel: fluorescence emission spectra of 0.8 μM (hexameric) IAEDANS-C246ClpB* 
(D; donor) and 0.8 μM fluorescein-peptide B1 (A; acceptor) without nucleotides (D + A) 
or with 3 mM ATP (D + A + ATP). Right panel: fluorescence emission spectra of 0.8 μM 
(hexameric) IAEDANS-C246ClpB* (D; donor) and 0.8 μM non-labeled peptide B1 (pB1) 
without nucleotides (D + pB1) or with 3 mM ATP (D + pB1 + ATP). Excitation 
wavelength was set at 336 nm. 
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Figure 6.12   FRET between IAEDANS labeled C104ClpB* and FITC-casein. 
Left Panel: fluorescence emission spectra of 0.8 μM (hexameric) IAEDANS-C104ClpB* (D; donor) and 1.5 μM FITC-
casein (A; acceptor) without nucleotides (D + A) or with 3 mM ATP (D + A + ATP). Right panel: fluorescence emission 
spectra of 0.8 μM (hexameric) IAEDANS-C104ClpB* (D; donor) and 1.5 μM non-labeled к-casein (casein) without 
nucleotides (D + casein) or with 3 mM ATP (D + casein + ATP). Excitation wavelength was set at 336 nm. 
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Figure 6.13   FRET between IAEDANS labeled C246ClpB* and FITC-casein. 
Left Panel: fluorescence emission spectra of 1.6 μM (hexameric) IAEDANS-C246ClpB* (D; donor) and 6 μM FITC-casein 
(A; acceptor) without nucleotides (D + A) or with 3 mM ATP (D + A + ATP). Right panel: fluorescence emission spectra of 
0.8 μM (hexameric) IAEDANS-C246ClpB* (D; donor) and 1.5 μM non-labeled к-casein (casein) without nucleotides (D + 
casein) or with 3 mM ATP (D + casein + ATP). Excitation wavelength was set at 336 nm. 
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CHAPTER 7 - Summary and Final Discussion 
 
The first part of this dissertation has been dedicated to the description of 
research oriented towards a better characterization of the ClpB architecture that 
supports the unique aggregation reversing capability of ClpB. Formation of ring-shaped 
oligomers is required for nucleotide binding and for the ATP-dependent protein 
remodeling activity of ClpB (Barnett et al., 2000).  
As high-resolution 3D structure of the oligomeric ClpB is lacking, a homology 
model of the E. coli ClpB hexamer was built based on an existing oligomeric model of 
the T. thermophilus ClpB (Diemand and Lupas, 2006) (Chapter 2). Although, such 
model is not a substitute for high resolution structure, it is a useful tool in exploration of 
the ClpB structure-function relationship.  
Additionally, in order to describe the conformational changes that occur in the 
various ClpB domains upon the oligomerization of the ClpB ring, we designed seven 
variants of ClpB each with a single Trp located in each of the ClpB domains. The 
thermodynamic stability of the distinct ClpB domains in monomeric and oligomeric forms 
was investigated by following the changes in Trp fluorescence during the equilibrium 
urea-induced unfolding. We found that the large sub-domain is the most stable, while 
the N-terminal domain and the middle domain are the least stable among the ClpB 
domains. Additionally, only two domains of ClpB were destabilized in the oligomeric 
form: the coiled-coil middle domain and the small sub-domain of the second AAA 
module. We conclude that only these two domains undergo significant conformational 
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changes during the formation of the oligomeric rings. The nucleotide-induced 
conformational changes of the Trp probes were also investigated, and several locations 
were found to respond to nucleotide-binding or hydrolysis (Chapter 3). 
The second part of this work includes the description of a novel filter assay, 
developed to study ClpB interactions with aggregated proteins. This assay was 
designed for the quick detection of the interaction between ClpB and strongly 
aggregated proteins with marginal solubility. Examples were provided where the filter 
assay was instrumental in detection of binding deficiencies of ClpB variants (Chapter 4). 
Chapter 5 describes the studies on the functionality of the two naturally-occurring 
ClpB isoforms. G6PDH reactivation assays demonstrated that the N-terminal domain of 
ClpB becomes essential for substrate binding as the size of the aggregates increase 
(Barnett et al., 2005). However, the major contribution of this work to the ClpB field is 
the discovery that the optimum chaperone activity of ClpB requires the cooperation of its 
two isoforms.  In an attempt to decipher the mechanism of this synergistic cooperation, 
we investigated the structural and functional characteristics of the two naturally 
occurring isoforms in isolation and when combined at different ratios. We found that the 
hetero-oligomers of ClpB95/ClpB80 posses a higher self-association affinity and an 
enhanced N-terminal domain mobility when compared to the homo-oligomers of Clp95. 
We also investigated the three major steps during the reactivation of aggregated 
substrates: binding, rate of substrate translocation through the ClpB oligomer (which is 
coupled to the ATPase activity), and the rate of substrate reactivation. We found that 
hetero-oligomers bind to aggregated substrates with a similar efficiency as homo-
oligomers of ClpB95, do not show enhanced ATPase activity over that of the homo-
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oligomers, but display a strongly stimulated chaperone activity during the reactivation of 
strongly aggregated proteins. We proposed that extraction of single polypeptides from 
aggregates and their delivery to the ClpB channel for translocation is the rate-limiting 
step in aggregate reactivation and this step is supported by the mobility of the N-
terminal domain of ClpB. We also suggest that the mobility of the N-domains is 
optimized for ClpB function.  
The last chapter of this work (Chapter 6) describes the design and production of 
single Cys variants of ClpB and their subsequent use in FRET experiments. Single Cys 
residues were introduced in proximity of two putative substrates binding sites (located in 
the N-terminal domain and at the entrance to the ClpB channel) and were successfully 
labeled with a fluorescent donor dye. We have demonstrated that FRET can be used to 
detect ATP-dependent interaction between donor labeled ClpB variants and acceptor 
labeled pseudo-substrates of ClpB. These new fluorescent tools will be instrumental in 
future research for the mapping of ClpB-aggregated substrate interaction sites, as well 
as for the investigation of the mechanism that controls the substrate extraction from the 
aggregated conglomerates and their insertion into the ClpB channel.  
Recently, major advances have been made that enhanced our understanding of 
the ClpB/DnaK system-mediated protein disaggregation. While several mechanisms 
were proposed, direct evidence only exist for the threading mechanism (as described in 
Chapter 1) (Weibezahn et al., 2004). The model presented in Fig. 7.1 summarizes our 
current understanding of the overall disaggregation process. Based on the accumulated 
experimental evidence, we propose to distinguish between three major steps during the 
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disaggregation: substrate recognition, insertion of the extracted polypeptide segment 
into the ClpB channel, and the subsequent threading through the ClpB channel.  
The overall disagregation process is dependent on the additional presence of the 
DnaK system and cooperation between ClpB and DnaK, but the precise role of this co-
chaperone system during the above described steps is still poorly understood. Direct 
interaction between ClpB and DnaK was not detected, but it was suggested by the 
observation that cooperation between the two chaperone systems is detected only 
between proteins of the same species.  (Glover and Lindquist, 1998; Schlee et al., 
2004)  
Besides functioning as a co-chaperone during ClpB-mediated protein 
disaggregation,  DnaK system is able to disaggregate certain small-sized aggregates in 
absence of ClpB also (top pathway in Fig. 7.1) (Diamant et al., 2000). Recent evidence 
also suggests that the conformational characteristics of the aggregates determine 
whether the additional presence of ClpB is needed for the disaggregation and the size 
of the aggregates is not the sole determinant. Interestingly disordered aggregates of a 
model substrate were disaggregated by DnaK system, while the reactivation of the 
aggregates with high β-structure content required the presence of ClpB (Lewandowska 
et al., 2007). 
In case of the aggregated substrates that require the cooperation between both 
chaperone systems, the order of interaction of the co-chaperones with the aggregates 
has not been elucidated. It has been shown that the DnaK system has an essential role 
during the initial steps of the disaggregation process, upstream from substrate 
translocation (Weibezahn et al., 2004). Kinetic studies revealed that preincubation of 
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aggregates with DnaK system results is a faster reactivation (Zietkiewicz et al., 2004) 
(also Chapter 5 of this work). This could suggest that productive ClpB-aggregate 
complex formation requires the DnaK system. ClpB interacts with substrates in an ATP-
bound conformation, but the detection of this complex is a challenging task due to the 
short life-time of the ATP-bond conformation of ClpB. Experiments with the trap version 
of ClpB that represents a frozen ATP-bond state of ClpB demonstrate that ClpB can 
recognize aggregated substrates in absence of the DnaK system (Weibezahn et al., 
2003) (also Chapter 5 of this work). 
 Interestingly, it was shown that ClpB (and also the yeast homolog: Hsp104) can 
disaggregate and reactivate small aggregates independently of the DnaK system, when 
mixtures of ATP and ATPγS are used in the reactivation assays. This DnaK 
independent activity of ClpB was also observed with ClpB variants that contained 
mutations in the ATP-binding sites in the first or the second AAA+ domain, in presence 
of ATP (Doyle et al., 2007). In can be suggested that when the ATPase activity of ClpB 
is decelerated, ClpB-aggregate interaction becomes more stable and ClpB can unfold 
the bound substrates. Based on the above observations we suggest that ClpBtrap 
stabilizes a functionally relevant state of ClpB that probably represents an intermediate 
state to the reactivation process (bottom pathway in Fig. 7.1). The pre-incubation 
experiments suggest that under physiological conditions (that is in absence of the trap 
variant of ClpB and ATPγS) DnaK system can prepare the aggregates for efficient 
interaction with ClpB by remodeling the surface of the aggregates and thus providing 
“stronger” recognition signals that allow for a stable initial interaction between 
aggregates and ClpB, which in turn is a prerequisite for the subsequent threading 
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(recognition step in Fig. 7.1). However, this initial recognition and stable interaction is 
not sufficient for initialization of the threading.  
Experiments with the two naturally occurring isoforms of ClpB prompted as to 
suggest that there is an intermediate step between the initial binding and the 
translocation that is rate limiting for the overall disaggregation. We proposed that this 
rate-limiting step (red arrow in Fig. 7.1) involves extraction of single polypeptides from 
the already bound aggregated substrates and their insertion into the ClpB channel for 
translocation. This is in agreement with previous experimental  results that showed that 
binding of aggregated substrates to the central pore of the ClpB channel, as well as the 
degradation by the engineered BAP-ClpP, requires cooperation with the DnaK system 
(Weibezahn et al., 2004; Haslberger et al., 2007) (also described in Chapter 1). It was 
proposed that nucleotide-dependent motions of middle domain of ClpB are necessary 
for the cooperation with the DnaK system (Haslberger et al., 2007).  
In conclusion we proposed that the N-terminal domains not only support the 
initial recognition and binding of aggregates, but their mobility possibly supports the rate 
limiting step of the disaggregation. Additionally, this rate-limiting step is also supported 
by the DnaK system of co-chaperones and possibly by the mobility of the middle 
domains.  
The ClpB-DnaK mediated protein solubilization and reactivation of aggregated 
proteins is of major importance in living cells. Bukau and co-workers have shown that 
removal of aggregated proteins by degradation is not sufficient. In order to ensure 
proper cell function, refolding and thus reactivation of the major cellular proteins is 
essential (Weibezahn et al., 2004).  
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The consequences of accumulation of aggregated proteins are deleterious for 
the living cells, as exemplified by the large number of severe neurorodegenarative 
diseases. Quite intriguingly, ClpB is only conserved in bacteria, plants, and fungi, but no 
orthologs were identified so far in higher eukaryotes. It has been emphasized that 
species that contain ClpB lack large-scale mobility and are unable to escape sudden 
changes in environment (Weibezahn et al., 2005).  
Recently, it has been proposed that the yeast Hsp104 may be useful as a 
therapeutic agent in elimination of the disease associated amyloids (Shorter, 2008).  It 
remains to be seen if such attempts could contribute to the development of effective 
treatments for the various neurodegenerative diseases. Meanwhile, future research 
regarding the details of substrate recognition, as well as the role of the ClpB-DnaK co-
operation , will be essential in understanding the intricate mechanism by which ClpB 
achieves its remarkable aggregation reversing activity. 
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Figures 
Figure 7.1   Model of ClpB-mediated protein disaggregation. 
 
 
